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Abstract 
Background and Literature Review: Anchorage is among the cities besieged by the alcohol and 
opioid crisis.  The city has numerous outpatient MAT programs and substance treatment settings 
that can provide outpatient detoxification programs.  Although the literature supports outpatient 
detoxification as feasible, safe, and affordable, it does not provide a specific model of outpatient 
detoxification.   The Alaska Treatment Center (ATC) offers outpatient detoxification based on a 
biopsychosocial model of detoxification.  Since the ATC outpatient detoxification seeks to 
expand treatment through this model, it is necessary to evaluate the patients’ experiences to 
improve clinical practice and substance treatment.  
Purpose: This project aimed to evaluate patient experiences in outpatient detoxification at ATC 
and identify promising strategies for improvement of the model to formulate strategic practice 
advancement using empirical data from participants.  
Methods: The project was quasi-experimental in design and informed by Lewin’s three stage 
change model.  Descriptive statistics of demographic and survey responses were presented using 
frequencies and percentages for categorical and ordinal variables.   A 45-item survey collapsed 
into three areas: the initial encounter, relationship during treatment, and overall impression.  A 
spearman’s rank correlation was conducted to test the internal consistency and construct validity 
of the instrument.  Statistical significance was set at p ≤ .05.  All analyses were conducted using 
SPSS Version 26.  
Implementation Plan/Procedure: The Generic Short Patient Experiences Questionnaire (GS-
PEQ) was modified and approved for use in this project by the University of Alaska Anchorage 
Institutional Review Board.  The survey instrument was administered to 42 participants who 
received outpatient detoxification from ATC. The findings revealed successful completion rate 
DocuSign Envelope ID: A8697833-AD7A-40DE-B71F-3A09BB6A364C
EVALUATING THE PATIENT EXPERIENCE IN OUTPATIENT    7 
of detoxification, with a significant correlation between before detoxification, rho = 0.1414, p = 
.007, and after detoxification, rho = -0.439, p = .769.   
Conclusion: The findings led to a modification of the ATC biopsychosocial model to encompass 
theoretical, contextual, conceptual, systematical, empirical, and implementational analysis.  
Consequently, flow charts, modified decision trees, and theory of change were integrated into the 
ATC policies and the electronic medical record.  The project revealed that detoxification is a 
vital step in substance treatment and may be successfully provided in outpatient treatment 
settings using the right model of treatment.  Organizational changes such as hiring additional 
staff and sharing the model with other MAT programs are still in progress. 
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Chapter 1: Introduction to the Problem, Purpose, and Aim 
 Outpatient detoxification offers an option for people to enter the process of recovery for 
substance use disorder and dependency.  This option incorporates a medically managed approach 
to addressing one of the most serious physical and behavioral health issues facing societies 
across the globe (American Society of Addiction Medicine [ASAM], 2019).  Through managed 
medical care, medically qualified professional, often nurse practitioners, prescribe, and manage 
medication that can offset the debilitating effects of withdrawal within a supportive, 
nonstigmatizing outpatient setting (ASAM, 2019; Holt, Dearmon, Lawrence, Lewis, & Skotzko, 
2017; U.S. Department of Health and Human Services, National Institute of Mental Health, and 
Substance Abuse and Mental Health Administration, 2019).  An alternative to inpatient 
treatment, outpatient detoxification  holds the promise of addressing recovery within the context 
of daily life, and it may offer a cost-effective option to what is often highly expensive inpatient 
detoxification care (Barry, Vinayaga-Pavan, Turner, & Wong, 2013; Carnwath, & Hardman, 
1998; Hayashida et al., 1989; Willey, Walker, Toffey, & Caughey, 2018). 
 The legitimacy of outpatient detoxification care is now approved for reimbursement, 
professional standards, and regulatory oversight.  It is no longer an emergent innovation, but 
rather it has garnered considerable support in the research literature by experts in addiction 
recovery and diffusion across the globe as a promising practice (ASAM, 2019; Corace et al., 
2019; U.S. Department of Health and Human Services, National Institute of Mental Health, and 
Substance Abuse and Mental Health Administration, 2019).  Controlled studies suggest 
outpatient detoxification offers patients a promising option to care and can facilitate entry into 
the continuum of recovery, as those patients seek to live a substance-free lifestyle through 12-
step programs, counseling, peer support, and/or clinical case management.   
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 The practitioner, herein referred to as the practitioner evaluator, evaluated the outpatient 
detoxification experience from the perspective of patients who attempt and/or complete this 
programmatic component of recovery.  Accordingly, survey methodology within a practitioner-
based evaluation framework was used to gather patients’ perspectives and experiences in a 
specific outpatient detoxification program in which he serves as medical director and provider.  
This evaluation captured relevant data from the perspective of patients undergoing outpatient 
detoxification for advancing the program itself as a model of care in addictions-based nursing 
practice.   
The evaluation supported learning about the design, implementation, and outcomes of the 
program to further improve the provision of care.  This project involved practitioner-focused 
action learning aimed at improving a practice model through the systematic use of data-based 
decision-making for the advancement of promising practice in substance use treatment.  Other 
practitioners may benefit from this project and experience and adopt, test, and use the outpatient 
detoxification model in their practice, thereby encouraging adaptation by—and utilization 
within—other treatment settings.  
Background  
Alcohol use disorder (AUD) refers to a clinically significant effect of alcohol use within a 
12-month period, leading to strong cravings and tolerance that impairs the ability to stop use on 
one’s own, causing hazardous physiological, social, and occupational impacts on the individual.  
Opioid use disorder (OUD) refers to a clinically significant impairment use of an opioid within a 
12-month period that induces strong cravings and tolerance that impairs the ability to stop use on 
one’s own, causing hazardous physiological, social, and occupational impacts on the individual.  
Individuals diagnosed with AUD and/or OUD will experience withdrawal when they stop using 
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the substance, which has unpleasant and painful psychological effects and, in some cases, can be 
fatal.  This means that patients seeking substance use treatment would first have to undergo 
detoxification.  Detoxification is the first phase of AUD/OUD treatment that prepares the brain 
physiologically and psychologically for the maintenance phase and long-term treatment.  
Detoxification refers to the physiological removal of toxins from the body through careful 
medical treatment.  Detoxification could take place in many settings but requires qualified 
practitioners in addiction medicine to ensure the safe stabilization of patients (American 
Psychiatric Association, 2013).  According to ASAM (2017), Level I and II ambulatory settings 
can provide detoxification for AUD/OUD withdrawal.  
The setting for this project was an ambulatory or outpatient ASAM-approved Level II 
facility located in the State of Alaska.  ASAM (2019) criteria for Level II ambulatory 
detoxification refers to intensive outpatient/partial hospitalization services with the capability of 
meeting the complex needs of patients with addiction and co-occurring conditions.  It delivers 
outpatient services, such as detoxification and counseling during the day, before and after work 
or school, and in the evening or weekend.  For this project, outpatient medication-assisted 
treatment (MAT) was the setting of focus.  The U.S. Department of Health and Human Services, 
National Institute of Mental Health, and Substance Abuse and Mental Health Administration 
(2019) defined MAT as the treatment of substance use disorder through combined therapeutic 
medication, counseling, and behavior modification.  Although federal regulation allows 
outpatient detoxification, a huge shortage of qualified providers to provide outpatient 
detoxification exists.  A qualified provider may be a physician, nurse practitioner, or physician 
assistant with at least 3 years of employment in an addiction setting to take the ASAM course to 
receive a waiver for the prescription of highly regulated drugs by the Drug Enforcement 
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Administration.  The state of Alaska has approximately 88 agencies that provide treatment 
services, of which 20 are located in Anchorage, the largest city in Alaska, with most services 
provided in outpatient settings.  This encompasses all programs for adults and youth and those in 
methadone clinics (Indian Health Services, 2018).  A visit to the 20 outpatient MATs in 
Anchorage revealed that only one (South Central Foundation of Anchorage Alaska) currently 
provides AUD/OUD detoxification for patients undergoing withdrawal in the outpatient 
addiction treatment center.   
The cost of AUD/OUD to the nation is about $740 billion annually.  The Alaska State 
Troopers report showed death related to alcohol and opioid overdose is on the increase, even 
with new training for the Anchorage law enforcement agency and naloxone kits to administer to 
patients (U.S. Department of Health and Human Services, National Institute of Mental Health 
and Substance Abuse and Mental Health Administration, 2019).  From 2012 to 2017, the rate of 
out-of-hospital naloxone administrations by emergency medical service personnel more than 
doubled from 8.0 to 17.7 administrations per 1,000 emergency service calls, respectively.  The 
rates of opioid-related inpatient hospitalizations were 28.5 per 100,000 persons in 2016 and 26.0 
per 100,000 persons in 2017, with total inpatient hospitalization charges exceeding $23 million 
(National Institute on Drug Abuse, 2019).  Alaska’s overdose death rate exceeded the national 
rate in 2015.  According to the Alaska Division of Behavioral Health, the highest number of 
opioid-related deaths identified in 1 year in Alaska was 108 in 2017; between 2010 and 2017, 
623 identified opioid overdose deaths were reported, and the opioid overdose death rate 
increased by 77% (as cited in Joshi, Weiser, & Warren-Mears, 2018).  The inadequate number of 
detoxification centers to promote continuity of care for patients with AUD/OUD contributes to 
the rampant rates of overdoses and deaths related to alcohol use (Schmidt et al., 2017).  The 
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expansion of addiction treatment centers is notable for reducing opioid overdose and curbing the 
crisis (Babu, Brent, & Juurlink, 2019). 
Clinical Significance  
 The project is grounded in the essentials of the Doctor of Nursing Practice (DNP) 
program and, therefore, reflects the values central to advanced nursing practice in addictions.  
The data-informed approach reflects the use of a scientific strategy to practice advancement.  
The project reflects the leadership the project evaluator is undertaking in the provision of 
addiction care in Alaska.  It also reflects provider advocacy for advancing addiction practice in 
Alaska, policy supporting the availability of addiction recovery, development of patient-centered 
intervention technology, and better organization of health care for people struggling with 
addiction, particularly AUD and/or OUD.  The project reflects the practitioner evaluator’s 
commitment to clinical scholarship in addictions recovery, the development of evidence-based 
intervention approaches, and the creation of models that support interprofessional collaboration 
in addiction practice.   
 The evolution of health care has moved highly centralized institutions into community-
based nursing practice.  Characterizing this evolution is the creation of models that are readily 
accessible, oftentimes provided at street level, flexible in use, and supporting maximum 
involvement of patients to encourage self-care.  This patient-centered approach is now taking 
root in addiction recovery where the rehabilitation process begins with engagement in medically 
managed withdrawal during which the patient can address symptoms that would otherwise 
undermine their motivation to achieve a substance-free lifestyle.  The sequencing of a given 
health technology moving from what was once delivered only in an inpatient setting into a 
community-based clinic can set the stage for continuity of care in recovery.  This continuity may 
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involve the transition into formal counseling and behavioral health interventions, peer support, 
and personal development opportunities.  The flexibility of outpatient detoxification can set the 
stage for a positive experience with few transitions, thereby contributing to a potentially 
seamless process of recovery.   
 The practitioner evaluator has focused on the Alaska Treatment Center (ATC) 
biopsychosocial model of addiction treatment by identifying and implementing an outpatient 
detoxification instrument. The approach was tested with 42 patients within the ATC 
organization, which encapsulated the eight DNP essentials.  
The project allowed the practitioner evaluator the opportunity to expand the clinical 
investigation and development process.  This is where patients’ perceptions of the process 
become especially meaningful.  By systematically testing the intervention, collecting data from 
users, and using this data in the process of clinical investigation and development, the 
practitioner evaluator created a model of effectiveness that could be established through 
subsequent systematic testing.  In this case, as with intervention design processes, outcome 
studies are relevant when assessing an operational model.  The practitioner evaluator has 
engaged in advanced practice through research and development in an actual treatment setting.  
A provisional approach to outpatient detoxication served as the focus of this project to improve 
the approach using feedback from patients.  This improvement process incorporates the 
underpinnings of a scientific method in health-care research and development. 
Problem Statement 
There is a tremendous need for outpatient detoxification in Anchorage, Alaska.  The lack 
of a feasible model that guides providers in the managing of outpatient MAT programs has led to 
fatal consequences for patients and the involvement of law enforcement (United States 
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Department of Justice, United States Attorney’s Office, & District of Alaska, 2019).  The 
practitioner evaluator gathered information from providers in the community revealed that, in 
Anchorage, almost all the outpatient MAT clinics maintain patients on suboxone for over 2 years 
without consideration to taper them down.  Also, most outpatient MAT programs do not provide 
detoxification to patients before they are started on maintenance drugs and counseling services.  
However, even at ATC where detoxification is offered, not all the patients continue care after 
stabilization.  The literature revealed the lack of continuity of care after detoxification may be a 
result of a poor detoxification process, counseling without detoxification, and starting 
maintenance drugs without detoxification, which has a high risk of recidivism and fatality 
(Acevedo, Garnick, Ritter, Lundgren, & Horgan, 2016; ASAM, 2019; Rossi, Faroni, Tassorelli, 
& Nappi, 2013). 
PICO and Clinical Evaluation Question and Rationale 
The PICO model is an evidence-based practice tool that helps in phrasing a clinical 
question directly related to the patient or problem at hand. The P stands for population of 
interest, the I stands for interventions, the C stands for comparison or alternative, and the O 
stands for the outcome being measured, improved, or affected (Dearholt & Dang, 2012). The 
clinical question guiding this project based on the PICO model is the following: What are the 
substantive improvements the practitioner evaluator can make to an existing model of outpatient 
detoxification to develop a more patient-responsive approach to care?  
The population (P) of interest was patients diagnosed with AUD/OUD and treated for 
withdrawal symptoms.  The intervention (I) was the model used for outpatient detoxification.  
The comparison intervention (C) was the current practice model as implemented at the ATC.   
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The expected outcome (O) of the project was an improved intervention model for outpatient 
detoxification provided at ATC.   
Statement of Principal Evaluation Aim 
The purpose of this DNP project was to evaluate the patient experience in outpatient 
detoxification.  Through data collection on the experiences of patients from the current model of 
outpatient detoxification, the practitioner evaluator engaged in a practice improvement of the 
model by using empirical data from participants.  The subquestions guiding the preceding 
clinical question in this inquiry were the following:  
1. How do the patients experience the current model of care?   
2. How do patients rate their satisfaction and quality of the experience?   
3. What are the correlates between how patients experience the current model of 
outpatient detoxification and the two principal outcomes of satisfaction and quality?   
4. What characteristics of the population and their addiction history correlate with 
patient-centered outcomes of care, satisfaction, and quality?   
5. What factors of the patient experience are predictive of patient-centered outcomes, 
which in this case are patient satisfaction and patient perceptions of quality?   
Appendix A provides details of the Generic Short Patient Experience Questionnaire (GS–PEQ) 
chosen as the instrument for the project which aligns with the PICO. 
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Chapter 2.  Literature Review 
An extensive database search was performed to obtain the most recent innovative work in 
the field of AUD/OUD.  The most recent studies were selected to supplement the robust 
evidence previous studies have provided for outpatient detoxification as an alternative for 
detoxifying AUD/OUD (Allan, 2000; Carnwath & Hardman, 1998; Isiadinso, 1977; Rabb, 
1981).  The databases used for this study were CINAHL, Cochrane Library, Science Direct, 
PubMed, PsychInfo, and ProQuest.  Databases were accessed mainly through the University of 
Alaska, Anchorage (UAA) Consortium Library.  Google Scholar and ASAM resources were also 
utilized.  The inclusion criteria were (a) qualitative, quantitative, experimental, quasi-
experimental, systematic, and meta-analysis studies; (b) published in English; (c) between 2013 
and 2019; (d) with contents relevant to the chosen topic on addiction; (e) published in full length 
and in peer-reviewed scientific journals; and (f) abstracts only for articles for which the full 
article could be obtained from the UAA interlibrary loan.  Exclusion criteria were (a) research 
not published in English; (b) research conducted by students and published in nonscientific 
journals; (c) partially published research without full abstract; and (d) studies published before 
2013 and after 2019. 
The search terms used were based on the PICO research question: What are the 
substantive improvements the practitioner evaluator can make to an existing model of outpatient 
detoxification to develop a more patient-responsive approach to care?  Search terms used were 
patient experiences in outpatient detoxification and alcohol, outpatient detoxification experiences 
for patients, detoxification and opioids, outcome of outpatient detoxification, ambulatory 
detoxification, ambulatory management of opioids, and ambulatory management of alcohol.  A 
combined result of all the articles collected from the databases entered into Zotero software 
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yielded 86 articles upon the removal of duplicates.  An abstract review of each article led to the 
removal of 52 articles using the inclusion criteria.  A manual review of the remaining 34 
documents yielded 24 articles using the exclusion criteria to remove 10 articles.  The 24 articles 
were examined for eligibility and yielded 14 articles because 10 of the 24 articles did not focus 
on outpatient detoxification.  The selected 14 studies had strong evidence to support outpatient 
detoxification of alcohol/opioid withdrawal.  The 14 studies selected were determined to be 
relevant, valid, reliable, and applicable to the PICO question.  The level of evidence of the 
studies, the degree to which the studies were conducted, and how each study answered the PICO 
question were significant in selecting these studies to support the project.  The chosen studies 
were 12 primary clinical studies and two systematic reviews.  In addition to the 12 studies, two 
supporting articles on the criteria for assessing patient experiences in outpatient settings were 
included (Haugum, Iverson, Bjertnaes, & Lindahl, 2017; Sjetne, Bjertnaes, Olsen, Iversen, & 
Bukholm, 2011).  One of the studies aligned well with ATC biopsychosocial model and was 
selected to be used as the instrument for evaluating patient experiences at ATC (Sjetne et al., 
2011).   Below are the components of the search in a Prisma. 
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Literature Informing Relevance of Outpatient Detoxification Programs 
The literature provided substantial data to support outpatient detoxification (Johnson & 
Faranone, 2013; Mannelli, Wu, Peindl, Swartz, & Woody, 2014; Sanders et al., 2013; Schmidt et 
al., 2017), and most of the strongest studies compared outcomes of effectiveness, feasibility, and 
affordability in support of outpatient detoxification (Bisaga et al., 2018; Brett, Lawrence, Ivers, 
& Conigrave, 2014; Corace et al., 2019; Deacon, Hines, Curry, Tynan, & Day, 2014; Ho & 
Adcock, 2017).  The rate of success in outpatient detoxification outcomes ranged from 50% to 
100% across the studies, whereas inpatient detoxification rates ranged from 3% to 78% (Ho & 
Adcock, 2017; Nadkarni et al., 2017).   
Literature Informing Theory and Practice of Outpatient Detoxification 
None of the studies provided a direct theoretical basis for detoxification but alluded to 
detoxification as a principal treatment in the initial stage of AUD/OUD treatment.  All of the 
studies, including independent government review findings provided strong evidential support of 
feasibility, affordability, and successful outpatient detoxification (Barry et al., 2013; Corace et 
al., 2019; Deacon et al., 2014; Ho & Adcock, 2017; Johnson & Faraone, 2013; Mannelli et al., 
2014; Schmidt et al., 2017; U.S. Department of Health and Human Services, National Institute of 
Mental Health, and Substance Abuse and Mental Health Administration, 2019).   
The methodology of the literature review covered the framework, theoretical perspective, 
sample characteristics, measurement of the major variables, data analysis of the findings, level of 
evidence and quality, and limitations in the literature.  The measurements of the major variables 
were the Clinical Opioid Withdrawal scale (COW), Clinical Instrument Assessment Scale 
(CIWA), and Diagnostic Statistical Manual Fifth Edition (DSM-V), with outcomes of successful 
outpatient detoxification, continuity of care, and affordability of care.  The population sample 
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ranged from 60 to 25,354 (Acevedo et al., 2016; Barry et al., 2013; Bisaga et al., 2018; Deacon 
et al., 2014; Ho & Adcock, 2017; Johnson & Faraone, 2013; Mannelli et al., 2014; Nadkarni et 
al., 2017; Sanders et al., 2013; Schmidt et al., 2017; Willey et al., 2018).  Using the John 
Hopkins Nursing Evidence-Based Tool, six of the studies met Level I for Quality A evidence 
(Acevedo et al., 2016; Barry et al., 2013; Bisaga et al., 2018; Brett et al., 2014; Corace et al., 
2019; Deacon et al., 2014; Ho & Adcock, 2017; Nadkarni et al., 2017).  
 Using the evidence-based nursing tool, two studies were rated at Level 1 with Quality B 
evidence.  The two studies were randomized, double-blind studies with a sufficient samples for 
the studies but not enough for generalizability (Barry et al., 2013; Sanders et al., 2013).  Six 
studies meeting Level II Quality A evidence were nonrandomized studies (Holt et al., 2017; 
Johnson & Faraone, 2013; Mannelli et al., 2014; McCarty et al., 2014; Schmidt et al., 2017).  A 
table synthesizing the evidence can be found in Appendix C.  
Gaps in Literature on Outpatient Detoxification Processes and Outcomes 
The gaps identified in the literature included a lack of utilization of the ASAM and 
SAMSHA criteria for outpatient detoxification and documented data about the patients’ 
experiences to determine the best model for outpatient detoxification.  Another gap in the 
literature was a lack of a specific theoretical framework for delivering outpatient detoxification. 
Factors Limiting Knowledge of Outpatient Detoxification 
The factors limiting knowledge of outpatient detoxification include the lack of 
practitioner education and the perception and belief that detoxification occurs in only inpatient 
settings (Corace et al., 2019; Holt et al., 2017).  Another principal factor is the lack of empirical 
data from patients’ experiences to support the model of detoxification in outpatient MAT 
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programs (Corace et al., 2019; Holt et al., 2017; Kamal, van Iwaarden, Dijkstra, & de Jong, 
2014).  
Need for and Relevance of Project 
Patients diagnosed with alcohol and/or opioid withdrawal need detoxification to continue 
to the next phase of substance treatment but may lack access to an inpatient setting; moreover, 
the existing outpatient MAT programs are not equipped with the human resources and logistics 
to provide outpatient detoxification (Corace et al., 2019).  High rates of recidivism and fatalities 
are seen among patients who do not continue treatment after the stabilization stage of 
detoxification (Sanders et al., 2013; Schmidt et al., 2017).  
How the Project Advances Clinical Practice  
 The outcome of the project will be used to create reliable and valid criteria for quality 
outpatient detoxification.  The current practice model will be modified based on the findings 
from the project to customize care to patient needs and enact sustainable measures for quality 
outpatient detoxification.  Identifying predictable variables of patients’ experiences that 
influence quality outcomes for detoxification may lead to the development of a future decision 
tree for outpatient detoxification programs.  
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Chapter 3: Organizational Framework 
Organizational Change Model 
Lewin’s (1974a, 1974b) model of change dominated the 20th century as an effective 
model in social services and business organizations; however, in the early decade of the 21st 
century, the model endured criticism as being too simplistic (Burnes, 2004; Burnes & Cooke, 
2013; Gold, 1999; Huarng & Mas-Tur, 2016).  Notwithstanding, Lewin’s model of change 
anchors the sustainable change needed in turbulent times and challenges facing the current 
health-care organization of the 21st century.  Lewin’s model theorized three stages of change: 
unfreezing, changing, and refreezing.  The unfreezing stage identifies the restraints and driving 
forces.  The driving forces are usually the facilitating factors, which include readiness, support of 
top executives, administrators, financial support, emotional, and psychological support.  The 
restraining forces are entrenched cultural and traditional practices of the organization, including 
individual beliefs, norms, and values.  The unfreezing stage destabilizes the current state of the 
organization and reinvents a need for change that resonates with the organization’s vision, 
mission, and values.   
Lewin’s change incorporates the organizational change of readiness in management.  The 
critics of Lewin’s model neglect the shrink and expansion theme within the model, which is 
similar to the theory of shrinkage and expansion of the universe in physics.  The change stage 
involves cognitive, behavioral, emotional, and psychological dynamic processes.  It is a three-
dimensional change that utilizes the component of the unfreezing stage while introducing new 
biopsychosocial management and organizational changes.  The three dimensions of unfreezing 
are the top executives, employees at the bottom of the ladder, and customers.  The changing 
stage examines the internal and external environment during implementation and ensures that the 
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internal environment will have a greater impact on the external environment.  The final stage of 
Lewin’s model involves refreezing.  This stage focuses on solidification and sustainability.  
Lewin’s model is the most appropriate model in addiction medicine to wedge and sustain a 
change from retrogressing to the old ways of operation both from the individual and 
organizational perspective (Gold, 1999). 
Components of Model 
Unfreezing stage. The unfreezing stage is the first stage of Lewin’s model.  The concepts 
of unfreezing in this project involve surveillance and examination of the traditional and ongoing 
practices in the treatment of patients diagnosed with AUD/OUD withdrawal.  The unfreezing 
stage asks thought-provoking questions and challenges the status quo based on current evidence-
based practice.  The unfreezing stage during its microscopic examination of the organization will 
destabilize the system of practice, making it clear to the organization and employees the danger 
of continuing in the old operational system.  The unfreezing stage relies on two internal factors 
to influence the external market.  The internal factors weighed against the external factors are the 
restraining and driving forces.  The restraining forces within the organizations will either be 
removed or allowed to adapt to the new innovative practices.  The driving factors within the 
organization use their authority to facilitate the breakdown of the barriers, while the early 
adopters of the organizational change influence their colleagues through collaboration and 
workplace support (Gold, 1999; Lewin, 1947a).  
 The stakeholders of the organization play a major role in destabilizing the organization; 
however, customers are the most active driving and restraining force.  During its evaluation, the 
unfreezing stage places the customer at the center of decision-making.  The unfreezing stage 
determines the readiness of the stakeholders, employees, and customers.  Using collected internal 
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and external data, education is designed for employees, stakeholders, and customers.  The model 
does not provide a specific process of collecting data and providing education: however, it 
indirectly infers that creating the perception for change requires the collecting of data to ensure 
top executives and key partners agree to a change.  The designed education assists in identifying 
readiness for change and creating a plan to usher the organization into change.  Without 
education, Lewin pointed out that there will be many people eager and ready to make the change 
but stagnant with unanswered questions concerning the present situation and next moves.  This 
involves a stakeholder analysis that focuses on the overall needs and expectations of the primary 
and secondary stakeholders and determines their readiness for change while providing 
transitional education.  Strategic design of the customers’ needs and the landscape of the 
organization serve as a guide throughout the entire change process (Gold, 1999; Lewin, 1947a, 
1947b). 
Moving/changing.  Moving/changing is the second stage of Lewin’s model, which 
involves brainstorming, presenting ideas, modeling, coaching, and mentoring.  The 
moving/changing stage also involves implementation and stakeholder engagement to create a 
cognitive, behavioral, and psychological change in the modus operandi of the organization.  This 
stage utilizes careful planning, effective communication, and transformational leadership to 
inspire and encourage change in employees.  The moving/changing stage aims to change the 
organizational culture, which epitomizes one of the overarching goals embedded in this DNP 
project: implementing a change in clinical practice (Burnes, 2004; Gold, 1999).  The model 
asserts that change in organizational culture is a fundamental component of leadership and must 
penetrate all aspects of the organization, including employees’ beliefs and values.  Those beliefs, 
DocuSign Envelope ID: A8697833-AD7A-40DE-B71F-3A09BB6A364C
EVALUATING THE PATIENT EXPERIENCE IN OUTPATIENT    25 
values, norms, and goals must align with the organization’s mission and vision of service 
(Burnes, 2004; Gold, 1999).  
  The overall moving/changing stage accelerates with resources from stakeholders, 
organizational structure and culture, primary consultants of change, and the interpersonal social 
and political skills to support the change process (Gold, 1999; Lewin, 1947a, 1947b).  The 
primary investigator responsible for implementing the detoxification in this outpatient setting 
must possess the technical knowledge and expertise to execute the plan for change.  The primary 
investigator must garner the economic resources, personnel, funds, and support in the internal 
and external environment with ethical guidelines for the change process, which is required by the 
UAA IRB. 
Refreezing-sustaining.  The final stage of Lewin's organizational model theorized that 
the sustainability of the change must be solidified as a habit encoded in the hearts and minds of 
the human resources of the organization and a new cultural code documented in the policies and 
procedures of the organization as the standard of procedure.  This process involves 
communication, retraining, reward, benefits and costs analysis, and evaluation and use of key 
performance indicators to socialize new employees and members into the system.  An 
organizational change model without a hedge of protection and sustainability risk not only 
administration and business loss but also, and most importantly, the customers’ commitment to 
continue services.  At the refreezing stage, positive reinforcement, reward, and acknowledgment 
of employees’ and customers’ efforts play a crucial role in the sustainability of the change 
implemented.  These norms and values are cemented into the organization’s culture to prevent 
individuals from reverting to the old ways (Gold, 1999; Lewin, 1947a).  Although this project 
focuses on the first phase of detoxification in the disease of addiction treatment, the second phase 
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is an integral component.  Lewin’s organizational model has a dynamic and humanistic approach 
that fits well with an integrated health-care organization.  The unfreezing stage will cause a 
shrink and create a sense of urgency and readiness for a model, supporting the momentum for 
change.  This change thrives on numerous foreseeable factors, such as quality of care, safety, and 
a positive impact on the internal and external environment.  The final stage ensures the new 
change becomes a habit and a culture that penetrates every aspect of the organization to establish 
equilibrium (Burnes, 2004; Gold, 1999).  
ATC is an outpatient MAT program that also provides behavioral medicine services for 
patients of any ethnic background.  The organization is licensed and approved to deliver MAT 
and behavioral medicine services by the Alaska Department of Drug Enforcement Agency and 
Healthcare Services.  The ATC uses a biopsychosocial model for outpatient detoxification, 
which is explained and depicted in Appendix D.  Lewin’s organizational change model fits well 
with the ATC biopsychosocial model of treatment because it is a linear modality with three 
phases: evaluation, detoxification, and continuity of care.  ATC biopsychosocial model refers to 
the three-dimensional process of detoxification to promote substance treatment and recovery; 
medical, psychological, and social support.  The first phase presupposes that if the selection 
criteria for outpatient detoxification is accurate, the detoxification process will be imbued with 
quality processes and successful outcomes of stabilization and readiness for continuity of care.  
The evidence for the linear relationships or linkages between the phases of alcohol/opioid 
detoxification when established will lead to the development of strategic measures to buttress the 
model after implementation.  
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Chapter 4: Description of Methods and Procedures 
Evaluation Design and Survey Methods 
The practitioner evaluator designed the evaluation using a survey method to capture data 
from participants about their first-time experience in outpatient detoxification provided by the 
ATC.  The instrument selected is a reliable and valid instrument for evaluating patient 
experiences in substance treatment (Sjetne et al., 2011).  The questionnaire was used to evaluate 
the patients’ experiences focusing on the outcomes they experience, the issues and challenges 
they face during treatment, and how they experience the linkages of the program to the next steps 
in the recovery process.   
The evaluation incorporated a sample of participants who attempted or completed 
treatment during the period of December 10, 2020, to July 6, 2020.   The design maximized 
sample size through the inclusion of those who attempted treatment, completed treatment, and 
entered treatment for AUD and/or OUD.  In its letter of support, ATC indicated a willingness to 
supply the necessary information required by the UAA IRB and HIPAA.  The center required 
IRB approval prior to allowing the practitioner evaluator to proceed with the data collection and 
evaluation.   
ATC staff were responsible for the collection of informed consent from potential 
participants.  The practitioner evaluator then proceeded to contact participants by email.  The 
email provided a brief description of the project and asked patients who are interested in 
participating to click on a Qualtrics link below the email message to complete the survey.  The 
evaluator followed up with patients two times before ceasing contact and, in the case of 
nonresponse, considered those as nonrespondents in the calculation of the response rate.  The 
practitioner evaluator sought a response rate of 75%.  To improve response rates, the practitioner 
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evaluator offered each potential participant an Amazon gift card when they completed the 
questionnaire.   
Management of data collection.  The practitioner evaluator entered the data into an 
Intellectus Statistics file as he received each completed and/or attempted questionnaire, noting an 
attempted questionnaire may contain missing data.  The project evaluator assigned a unique 
patient identifier from 001 to 050 and treated each item as a variable.  To ensure that a variable 
was assigned a name, label, and value, quantitative numeric values were completed.  The 
practitioner evaluator coded all missing data as 9, so he could remove those from subsequent 
analysis.  
 Questionnaire design.  The 45-item questionnaire was adopted from the Generic Short 
Patient Experiences Questionnaire and modified by removing not applicable items and adding 
nine questions (Sjetne et al., 2011).  The GSPEQ is not a copyrighted questionnaire, and the 
public can modify and use it for clinical research and practice (Sjetne et al., 2011).  The 
structured but open-ended items captured the experience of outpatient treatment at ATC in the 
participants’ own words and phrases.  The data analytic questions identified and captured the key 
concepts for each area of the generic questionnaire: patients’ (a) initial relationship with ATC, 
(b) relationship during treatment, (c) relationship and impression after treatment.  Demographic 
and severity of addiction history questions were placed at the beginning of the questionnaire.  
The questionnaire has been shown to be reliable and valid in evaluating patient experiences from 
substance treatment.  A study that evaluated 516 patients in an outpatient setting using these 
questions reported statistically significant (p > .05) results, and the relationship between each 
item showed a Spearman correlation coefficient range of 0.11 to 0.59, 17 out of 19 of its items 
(89%).  When the remaining two items were removed, a statistical significance was still obtained 
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from a Spearman rank correlation coefficient recalculation, which reduced the p-value from .92 
to .90 (p < .05; Sjetne et al., 2011; Wong et al., 2015). 
Steps in the data analytic process.  Upon receiving responses in Qualtrics, a run of 
frequencies to investigate each of the principal data analyses and observe the general trends in 
the patients’ responses in each area of the treatment process were performed.  The next step was 
to measure central tendency, standard deviation, and skewness of items.  The demographic and 
addiction history were used as dependent variables and detoxification was analyzed as the 
independent variable.  The items were condensed into three models: (a) initial encounter 
relationship, (b) relationship during treatment, and (c) overall impression after treatment.  The 
items were coded as problem scores, which provides a subjective evaluation of the area of care 
that could be improved.  Construct validity was evaluated using Spearman rank correlation of the 
summative problem scores calculated.  The Cronbach’s alpha coefficient and the item-to-total 
coefficient were estimated to test the item internal consistency reliability of the instrument, 
which assessed whether the items measured the same concept.  The analysis of the data explored 
the relationship of the categorical variables using Spearman correlation.   
Implementation Plan 
Project implementation objective.  The objectives for the implementation of the project 
were the following: (a) to obtain data on the experiences of patients from the designed model of 
outpatient detoxification at ATC, (b) to identify practice strategies for improvement of the 
model, and (c) to formulate strategic practice advancement using empirical data from 
participants to improve the model for clinical practice. 
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Key project activities.  The pertinent activities of this project included selecting an 
appropriate survey questionnaire instrument that addresses the aims of the project, seeking 
approval of the committee, submitting to IRB for approval, distributing the survey questionnaires 
to qualified participants via email, collecting the data, coding, and running data analysis.  The 
next step involved preparing the manuscript describing the project and using the empirical data 
to improve the model for clinical practice at ATC and dissemination of results to MAT 
programs. 
 Cost-benefit analysis and budget.  A projected cost-benefit analysis of the project can 
be found in Appendix E.  The main costs associated with the project were paper, printing, ink, 
statistical analysis review, and a $25 Amazon gift card for each potential participant.   
Schedule for project completion: Implementation, evaluation, and dissemination. 
This project was conducted between August 14 and September 2020 since IRB approved the 
project on August 12, 2020.  The final project defense was changed from November 2020 to the 
spring semester of 2021 (see Appendix F for the project timeline).  
Evaluation Plan 
The practitioner evaluator used the adapted survey questionnaire to conduct a systematic 
analysis of the responses and their importance to the improvement of the biopsychosocial model.  
The independent variables relevant to the outcome of outpatient detoxification were utilized to 
strategically improve the quality of clinical practice in detoxification at ATC outpatient 
detoxification program.  The practitioner evaluator examined the statistical and clinical 
significance of the data to inform a sustainable outpatient detoxification practice change at ATC 
integrated health program. 
DocuSign Envelope ID: A8697833-AD7A-40DE-B71F-3A09BB6A364C
EVALUATING THE PATIENT EXPERIENCE IN OUTPATIENT    31 
Implications for Advanced Practice  
Theoretical implication for outpatient detoxification.  Based on the literature 
supporting evidence for outpatient detoxification, Lewin’s change model will imperatively assert 
the need for change in outpatient MAT programs treatment of AUD/OUD to include 
detoxifications as the essential step in the initial stage of treatment. The biopsychosocial 
underpinning of detoxification illuminates the quality outcomes of the treatment process for 
patients. 
 Implications for practice in outpatient detoxification.  The advancement of the 
current model may provide a holistic reliable selection criterion of appropriate patients for 
outpatient detoxification with a higher probability of continuing care after detoxification.  The 
quality patient outcomes will enhance the promotion of outpatient detoxification in ATC and 
external MAT programs.  
Implications for Practice Improvement Through Action Learning 
ATC MAT program outcomes from the perspective of AUD/OUD patients’ experience 
with detoxification will generate the need for reflection and utilization of findings to modify the 
current designed model with the potential to customize the unique needs of each patient.  Sharing 
results with the clinical team of the organization may generate new ideas and create therapeutic 
and strategic advancement for clinical practice through modification of the current detoxification 
model. 
Implications for the Evaluator/Practitioner   
The findings from the project will be used to improve clinical decision-making for the 
detoxification of AUD/OUD patients.  The empirical data results will be used to make changes 
for AUD/OUD patients and to educate and offer staff the opportunity to provide their input on 
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how to improve quality outcomes of detoxification.  The modification of the current model of 
detoxification will be used to expand the practice to accept more patients for substance 
treatment.  The findings will be used to improve quality patient outcomes to a logic model 
consistent with the six domains of health-care quality and Health Effectiveness Data and 
Information Set for AUD/OUD treatment (Agency for Health Research and Quality, n.d.). 
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Chapter 5: Implementation Process and Procedures 
The implementation phase of the ATC biopsychosocial model of outpatient detoxification 
was facilitated by the following principles: theoretical, systematic, conceptual, implementation 
analysis, and empirical analysis.  The central theme of these principles stems from the proposed 
method, which condensed the 45 items into three significant areas to evaluate the patient 
experience of the ATC biopsychosocial model of outpatient detoxification.  These three items—
initial encounter relationship, relationship during treatment, and overall impression after 
treatment—encapsulate the objectives of the implementation: (a) to obtain data on the 
experiences of patients from the designed model of outpatient detoxification at the ATC, (b) to 
identify practice strategies for improvement of the model, and (c) to formulate strategic practice 
advancement using empirical data from participants to improve the model for clinical practice. 
Systematic Plans for Implementation 
The ethics of conducting a project at ATC was evaluated because the project lead is the 
owner of the center.  A consultation with the Chair and committee of the project provided 
specific requirements to be met for the project to take place at the ATC.  The board of directors' 
agreement to support the project and ensure the objectivity of the project was secured, allowing 
the project to commence.  The clinical director provided a letter of support and guidelines to 
ensure that the collection of data would not compromise the patients’ confidentiality and safety.  
The project could not start without the UAA IRB approval letter to the ATC's clinical director.  
The requirements of the UAA IRB were similar to those of the ATC except that UAA required 
the use of a Qualtrics instrument for collecting data without IP address tracing.  The instrument 
selected to collect data and evaluate patients' experiences in the ATC outpatient detoxification 
program was reviewed again by ATC management to ensure it met the Health Insurance 
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Accountability Act (HIPAA) guidelines and that no patients' confidentiality and rights would be 
breached.  
Potential participants were invited via email, and those who agreed to participate 
signed/refused to consent anonymously by a mouse click.  The consent form was part of the 
Qualtrics website link sent to potential participants.  This allowed those who agreed to 
participate to click on the link, which opened the consent for their review, after which they could 
click on “Yes, I agree” or “No, I do not agree.” 
Participants had 2 weeks to respond to the survey items, and the questionnaire closed at 
the end of the second week.  At the end of the second week, 42 responses were received out of 
50 potential participants.  The 45 items of the questionnaire were estimated to take less than 15 
minutes to complete.  A separate questionnaire was provided for participants to claim a $25 
Amazon gift card.  Separating the questionnaire for claiming the gift card was an IRB 
requirement to ensure participants' anonymity was maintained.  The first report was run in 
Qualtrics to review the descriptive statistics.  The Excel files of the report were downloaded and 
cleaned, after which they were analyzed using SPSS version 26 software package.  The Excel 
files of the report were downloaded because it cannot be cleaned in Qualtrics and transfer 
directly from Qualtrics to SPSS.  
The statistical analysis was then interpreted and evaluated within the context of the ATC 
biopsychosocial model of detoxification.  The statistical analysis was done based on the 
objectives of the implementation discussed in Chapter 4: (a) to obtain data on the experiences of 
patients from the designed model of outpatient detoxification at the ATC, (b) to identify practice 
strategies for improvement of the model, and (c) to formulate strategic practice advancement 
using empirical data from participants to improve the model for clinical practice.  The 
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breakdown of these three objectives was before detoxification, during detoxification, and after 
detoxification.  This was based on Q3. How would you rate the satisfaction of the following 
aspect of detoxification received from Alaska Treatment Center? 
 
 Very 
Satisfied   














    
  The findings from the project revealed some significant outcomes that are clinically 
relevant to patient experiences.  This led to the modification of the ATC biopsychosocial 
detoxification for outpatients.  The transformation included incorporating a decision tree 
(algorithm), a flow chart, and theory of change into the ATC model of detoxification and policy. 
Implementation Process 
In Chapter 3, Kurt Lewin's organizational framework was discussed in detail to explain 
why it was the best framework for the implementation of this project.  This project was 
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implemented using Kurt Lewin's organization framework in the following three stages: 
unfreezing, changing/moving, and refreezing/sustaining.  The unfreezing stage in this project 
took place upon receiving approval from the IRB.  The ATC biopsychosocial model of 
detoxification was evaluated, including the decision tree for detoxification and other assessment 
tools used by the organization.  The organization's beliefs, values, and vision were at the center 
of the unfreezing process.  This stage aimed to understand why the organization performs 
outpatient detoxification, what the organization aims to achieve, and how the model of ATC 
outpatient detoxification can be improved for quality delivery of services (Gold, 1999; Lewin, 
1947a, 1947b). 
The changing/moving phase of the project focused on three areas: management, staff, and 
patients.  The readiness of management for this change was reflected in their willingness to 
review the instruments selected to examine patient detoxification experiences at ATC.  The 
staff’s willingness to support change was manifested by spearheading the invitation of potential 
participants and sending the questionnaire to participants.  The availability of eligible 
participants and their willingness to participate accelerated the changing phase of 
implementation.   
In addition to the resources from ATC management and staff, the project lead's technical 
knowledge and expertise in evaluating and modifying the instruments were important 
components in achieving the outcome of the implementation.  The participants were promised 
$25 Amazon gift cards, which were redeemable upon completing the main questionnaire and 
completing a separate questionnaire for claiming the Amazon gift card. 
Refreezing/sustaining is the final stage of Lewin's organizational framework.  Lewin 
asserted that to sustain implemented change, that change must be encoded and solidified into the 
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culture of an organization (Huarng & Mas-Tur, 2016).  This process requires retraining, reward, 
benefits, cost analysis, and the use of key performance indicators to socialize new employees and 
members into the system.  As part of the empirical implementation of a modified model of 
detoxification, ATC committed to hiring additional staff and counselors to ensure patients 
receive all their care from the same organization, thus enhancing continuity of care. 
Barriers and Challenges 
The barriers to this project included the inability to administer the questionnaire in 
person, the population's vulnerability, and the difficulty in defining the project as either a quality 
improvement study or a project.  Due to the COVID-19 pandemic, the UAA IRB prohibited all 
in-person research and projects.  This precluded the possibility of performing observation 
research or a study.  The population selected for this project was patients with AUD and/or 
OUD, who constitute one of the most vulnerable populations.  Due to the stigmatization faced by 
this population and the sensitivity involved in researching this topic, many restrictions were 
required by the UAA IRB.  Some of the IRB requirements, such as using a nontraceable IP 
address, posed considerable challenges, including securing a subscription to a version of 
Qualtrics that could not trace participants’ IP addresses because the practitioner evaluator spent 
more than necessary time researching on how to accomplish this requirement.  Another challenge 
emanating from the vulnerability of the target population was the use of staff rather than the 
primary investigator to send the invitation letter and Qualtrics link to potential participants.  The 
controversy about whether the DNP project was a research study was a major barrier between the 
original project and the revised scheme.  
 Although the project was an empirical study, the use of the term “research” and the first 
proposed title (Algorithm for Selecting Appropriate Patients for Detoxification in an Outpatient 
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MAT Program) raised numerous concerns regarding aims, ethics, and methods.  This led to the 
revision of the first proposal.  Although the revision was a challenge that was eventually 
overcome, its timing was a barrier to developing an instrument that would have yielded 
variations in the responses.  This lack of variation from the short generic metric is reflected in the 
results of the project's findings and motivates future studies to develop a metric for evaluating 
patient experiences of the ATC biopsychosocial model for outpatient detoxification.  
 The project's most challenging aspect was the effect of the COVID-19 pandemic on health-care 
organizations and businesses.  Across the globe, COVID-19 has brought major changes to 
research and creative activities, especially those of educational institutions.  The initial project 
was aimed at educating three central emergency departments in Anchorage to use the developed 
algorithm to identify patients seeking detoxification and refer them to ATC for treatment.  In 
addition to raising theoretical issues with the use of the term “algorithm,” this initial project was 
ultimately impractical due to COVID-19.  Generally, outpatient detoxification challenges include 
the risk of fatality, recidivism, and the perception that it cannot be accomplished in an outpatient 
setting.  Although these were not the challenges of this project, the lack of any other outpatient 
detoxification clinic in Anchorage with which to do a comparison study was a concern. 
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Chapter 6: Evaluation and Synthesis of Outcomes 
Methods 
The primary purpose of this project was to examine patient experiences at ATC and 
determine what areas of care need the most improvement.  Data were collected from 42 survey 
respondents.  Descriptive statistics of demographic and survey responses were presented using 
frequencies and percentages for categorical and ordinal variables.   Measures of central tendency, 
including mean, median, standard deviation, and skewness of each of the survey items were 
examined.  The survey items were condensed into three models: initial encounter relationship, 
(b) relationship during treatment, and (c) overall impression after treatment.  
The survey items were coded as problem scores, which provide a subjective evaluation of 
the area of care that could be improved.  A principal component analysis (PCA) was first 
performed to assess if subdimensions existed in the survey items.  If the PCA was uninformative 
and no natural groupings of variables were found in the data, Spearman’s rho correlations were 
calculated between each of the individual survey items and the outcome detoxification ratings, 
and those with the strongest correlations were used to calculate the problem scores.  The problem 
scores were calculated as the sum of the individual survey items having the strongest correlations 
with each of the outcomes.  Cronbach’s alpha coefficient was estimated to test the internal 
consistency of the instrument and assess whether the items measured the same concept.  
Construct validity was evaluated using Spearman’s rank correlation between the calculated 
summative problem scores and each of the three detoxification outcomes: before, during, and 
after treatment.  Statistical significance was defined as a p-value ≤ .05.  All analyses were 
performed in SPSS version 26. 
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Results 
Table 1 shows the descriptive statistics of the 42 respondents to the survey.  Note that for 
the importance (Part B) questions in the survey, the majority of respondents rated each item as 
“Extremely important.” 
Table 1  
 
Descriptive Statistics of Sample 
 
 
Variable Value N % 
Q1: What was the severity rating of your condition? Mild 16 38.1% 
 Moderate 8 19.0% 
 Moderate-Severe 11 26.2% 
 Severe 6 14.3% 
 Missing 1 2.4% 
Q2: Did you have any of the following underlying 
conditions? 
Major depressive disorder in 
full or partial remission 
12 28.6% 
 Anxiety disorder in full or 
partial remission 
11 26.2% 
 Type 2 diabetes with A1C 
>12 
1 2.4% 
 Hypertension with BP > 
140/90 
5 11.9% 
 None 13 31.0% 
Q3#1_1: How would you rate your satisfaction with the 
following aspect of detoxification received from Alaska 
Treatment Center: First encounter with practitioner 
(Evaluation)? 
Very Dissatisfied 0 0.0% 
 Dissatisfied 2 4.8% 
 Very Satisfied 36 85.7% 
 Satisfied 4 9.5% 
Q3#1_2: How would you rate your satisfaction with the 
following aspect of detoxification received from Alaska 
Treatment Center: Withdrawal and treatment? 
Very Dissatisfied 0 0.0% 
 Dissatisfied 1 2.4% 
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Variable Value N % 
 Very Satisfied 36 85.7% 
 Satisfied 5 11.9% 
Q3#1_3: How would you rate your satisfaction with the 
following aspect of detoxification received from Alaska 
Treatment Center: Readiness for continuity of care? 
Very Dissatisfied 0 0.0% 
 Dissatisfied 0 0.0% 
 Very Satisfied 35 83.3% 
 Satisfied 7 16.7% 
Q4: What is your gender? Male 15 35.7% 
 Female 26 61.9% 
 Missing 1 2.4% 
Q5: What is your ethnicity? African American 6 14.3% 
 Caucasian 30 71.4% 
 Hispanic 2 4.8% 
 Alaskan Native 0 0.0% 
 Mixed Race 3 7.1% 
 Missing 1 2.4% 
Q6: How old are you? 18-29 13 31.0% 
 30-39 8 19.0% 
 40-49 14 33.3% 
 50-59 4 9.5% 
 60 and above 3 7.1% 
Q9: Did Alaska Treatment Center help you accomplish 
your treatment goal? 
Yes 41 97.6% 
 No 1 2.4% 
Q10b_A: Did the clinicians talk to you in a way that was 
easy to understand 
Not at all 0 0.0% 
 To a small extent 0 0.0% 
 To a moderate extent 5 11.9% 
 To a larger extent 37 88.1% 
Q10b: How important was this topic to you? Extremely important 35 83.3% 
 Very important 5 11.9% 
 Moderately important 1 2.4% 
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Variable Value N % 
 Slightly important 1 2.4% 
 Not at all important 0 0.0% 
Q11a: Did you have confidence in the clinician's 
professional competence? 
Not at all 1 2.4% 
 To a small extent 0 0.0% 
 To a moderate extent 4 9.5% 
 To a larger extent 37 88.1% 
Q11b: How important was this to you? Extremely important 35 83.3% 
 Very important 4 9.5% 
 Moderately important 2 4.8% 
 Slightly important 1 2.4% 
 Not at all important 0 0.0% 
Q12a: To what degree did you perceive that the clinicians 
cared about you? 
Not at all 1 2.4% 
 To a small extent 1 2.4% 
 To a moderate extent 8 19.0% 
 To a larger extent 32 76.2% 
Q12b: How important was this to you? Extremely important 37 88.1% 
 Very important 1 2.4% 
 Moderately important 3 7.1% 
 Slightly important 1 2.4% 
 Not at all important 0 0.0% 
Q13a: Did you get enough time to talk and interact with 
the clinicians? 
Not at all 1 2.4% 
 To a small extent 1 2.4% 
 To a moderate extent 8 19.0% 
 To a larger extent 31 73.8% 
 Missing 1 2.4% 
Q13b: How important was this to you? Extremely important 35 83.3% 
 Very important 3 7.1% 
 Moderately important 2 4.8% 
 Slightly important 1 2.4% 
 Not at all important 1 2.4% 
Q14a: Did the other staff talk to you in a way that was 
easy to understand? 
Not at all 0 0.0% 
 To a small extent 2 4.8% 
 To a moderate extent 10 23.8% 
 To a larger extent 30 71.4% 
Q14b: How important was this to you? Extremely important 27 64.3% 
 Very important 9 21.4% 
 Moderately important 3 7.1% 
 Slightly important 2 4.8% 
DocuSign Envelope ID: A8697833-AD7A-40DE-B71F-3A09BB6A364C
EVALUATING THE PATIENT EXPERIENCE IN OUTPATIENT    43 
Variable Value N % 
 Not at all important 1 2.4% 
Q15a: Do you have confidence in the other staff's 
professional skills? 
Not at all 0 0.0% 
 To a small extent 4 9.5% 
 To a moderate extent 12 28.6% 
 To a larger extent 25 59.5% 
 Missing 1 2.4% 
Q15b: How important was this to you? Extremely important 28 66.7% 
 Very important 7 16.7% 
 Moderately important 4 9.5% 
 Slightly important 2 4.8% 
 Not at all important 1 2.4% 
Q16a: To what degree did you perceive that the other 
staff cared about you? 
Not at all 0 0.0% 
 To a small extent 5 11.9% 
 To a moderate extent 9 21.4% 
 To a larger extent 28 66.7% 
Q16b: How important was this to you? Extremely important 25 59.5% 
 Very important 8 19.0% 
 Moderately important 5 11.9% 
 Slightly important 1 2.4% 
 Not at all important 2 4.8% 
 Missing 1 2.4% 
Q18a: Did you perceive the other staff to be interested in 
your description of your situation? 
Not at all 1 2.4% 
 To a small extent 5 11.9% 
 To a moderate extent 8 19.0% 
 To a larger extent 28 66.7% 
Q18b: How important was this to you? Extremely important 29 69.0% 
 Very important 6 14.3% 
 Moderately important 3 7.1% 
 Slightly important 2 4.8% 
 Not at all important 2 4.8% 
Q19a: Did you get enough time to talk and interact with 
the other staff? 
Not at all 1 2.4% 
 To a small extent 3 7.1% 
 To a moderate extent 8 19.0% 
 To a larger extent 29 69.0% 
 Missing 1 2.4% 
Q19a: How important was this to you? Extremely important 30 71.4% 
 Very important 5 11.9% 
 Moderately important 3 7.1% 
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Variable Value N % 
 Slightly important 4 9.5% 
 Not at all important 0 0.0% 
Q20a: Were you given the necessary information about 
how detoxification would be carried out? 
Not at all 0 0.0% 
 To a small extent 1 2.4% 
 To a moderate extent 2 4.8% 
 To a larger extent 39 92.9% 
Q20b: How important was this to you? Extremely important 36 85.7% 
 Very important 4 9.5% 
 Moderately important 1 2.4% 
 Slightly important 1 2.4% 
 Not at all important 0 0.0% 
Q21a: Did you get sufficient information about your 
diagnosis? 
Not at all 0 0.0% 
 To a small extent 0 0.0% 
 To a moderate extent 6 14.3% 
 To a larger extent 36 85.7% 
Q21b: How important was this to you? Extremely important 36 85.7% 
 Very important 2 4.8% 
 Moderately important 2 4.8% 
 Slightly important 2 4.8% 
 Not at all important 0 0.0% 
Q22a: Did you perceive the treatment you received as 
suited to your situation? 
Not at all 1 2.4% 
 To a small extent 1 2.4% 
 To a moderate extent 7 16.7% 
 To a larger extent 33 78.6% 
Q22b: How important was this to you? Extremely important 34 81.0% 
 Very important 4 9.5% 
 Moderately important 3 7.1% 
 Slightly important 1 2.4% 
 Not at all important 0 0.0% 
Q23a: Were you involved in any decision involving your 
treatment? 
Not at all 0 0.0% 
 To a small extent 3 7.1% 
 To a moderate extent 6 14.3% 
 To a larger extent 33 78.6% 
Q23b: How important was this to you? Extremely important 32 76.2% 
 Very important 4 9.5% 
 Moderately important 4 9.5% 
 Slightly important 1 2.4% 
 Not at all important 0 0.0% 
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Variable Value N % 
 Missing 1 2.4% 
Q24a: Did you perceive the institution’s work as well 
organized? 
Not at all 0 0.0% 
 To a small extent 3 7.1% 
 To a moderate extent 6 14.3% 
 To a larger extent 33 78.6% 
Q24b: How important was this to you? Extremely important 32 76.2% 
 Very important 3 7.1% 
 Moderately important 3 7.1% 
 Slightly important 4 9.5% 
 Not at all important 0 0.0% 
Q25a: To what extent did Alaska Treatment Center 
prepare you for continuity of care after the detoxification? 
Not at all 0 0.0% 
 To a small extent 2 4.8% 
 To a moderate extent 3 7.1% 
 To a larger extent 37 88.1% 
Q25b: How important was this to you? Extremely important 35 83.3% 
 Very important 4 9.5% 
 Moderately important 0 0.0% 
 Slightly important 1 2.4% 
 Not at all important 2 4.8% 
Q26a: To what extent did the organization work with 
other facilities to ensure your smooth transition to the 
next phase of substance treatment after detoxification? 
Not at all 0 0.0% 
 To a small extent 2 4.8% 
 To a moderate extent 3 7.1% 
 To a larger extent 37 88.1% 
Q26b: How important was this to you? Extremely important 32 76.2% 
 Very important 5 11.9% 
 Moderately important 3 7.1% 
 Slightly important 1 2.4% 
 Not at all important 1 2.4% 
Q27a: Did you have to wait after your initial evaluation to 
be scheduled for detoxification at ATC? 
No 24 57.1% 
 Yes, but not long 6 14.3% 
 Yes, quite long 3 7.1% 
 Yes, much too long 9 21.4% 
Q27b: How important was this to you? Extremely important 34 81.0% 
 Very important 5 11.9% 
 Moderately important 3 7.1% 
 Slightly important 0 0.0% 
 Not at all important 0 0.0% 
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Variable Value N % 
Q28a: Overall, what benefit have you had from the care 
at the institution? 
No benefit 0 0.0% 
 Small benefit 0 0.0% 
 Some benefit 2 4.8% 
 Great benefit 17 40.5% 
 Huge benefit 23 54.8% 
Q28b: How important was this to you? Extremely important 37 88.1% 
 Very important 4 9.5% 
 Moderately important 1 2.4% 
 Slightly important 0 0.0% 
 Not at all important 0 0.0% 
 
 
Tables 2a (Appendix H) and 2b (Appendix I) are the results of the oblique-rotated PCA 
loadings of each of the Part A and Part B questions, respectively.  The PCA analysis used three 
components to assess if natural groupings existed that could represent the before, during, and 
after treatment problem scores.  The PCA results were minimally informative, as most items are 
loaded onto one principal component (PC1) due to the lack of variability in the responses across 
items. 
Spearman’s rho correlations between each of the individual survey items and the before 
(Q3#1_1), during (Q3#1_2), and after (Q3#1_3) detoxification ratings are shown in Table 3.  
Items Q15a, Q16a, and Q24a have significant correlations with the detoxification rating before 
treatment.  Items Q10b_A and Q20a have significant correlations with the detoxification rating 
during treatment.  Items Q11a, Q12a, Q13a, Q19a, Q22a, Q23a, and Q28a have significant 
correlations with the detoxification rating after treatment.  Q14a and Q21a have the highest 
correlations with the detoxification rating before treatment, although these correlations were not 
statistically significant.  Likewise, Q18a has the highest correlations with the detoxification 
rating after treatment, although not significant.  Q25a and Q26a were the questions most relevant 
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to detoxification rating, although the correlations with that outcome were weak.  Q27a had a 
weak correlation with all the detoxification rating outcomes. 
Table 3. 






Q10b_A: Did the clinicians talk to you in 
a way that was easy to understand 
Q3#1_1 -0.150 0.344 
 Q3#1_2 -0.310 0.046 
 Q3#1_3 -0.230 0.143 
Q11a: Did you have confidence in the 
clinician's professional competence? 
Q3#1_1 0.257 0.100 
 Q3#1_2 -0.097 0.540 
 Q3#1_3 -0.436 0.004 
Q12a: To what degree did you perceive 
that the clinicians cared about you? 
Q3#1_1 0.106 0.505 
 Q3#1_2 0.026 0.871 
 Q3#1_3 -0.391 0.011 
Q13a: Did you get enough time to talk 
and interact with the clinicians? 
Q3#1_1 0.109 0.498 
 Q3#1_2 0.030 0.851 
 Q3#1_3 -0.388 0.012 
Q14a: Did the other staff talk to you in a 
way that was easy to understand? 
Q3#1_1 0.214 0.174 
 Q3#1_2 0.032 0.842 
 Q3#1_3 0.147 0.353 
Q15a: Do you have confidence in the 
other staff's professional skills? 
Q3#1_1 0.332 0.034 
 Q3#1_2 0.082 0.611 
 Q3#1_3 -0.114 0.478 
Q16a: To what degree did you perceive 
that the other staff cared about you? 
Q3#1_1 0.362 0.018 
 Q3#1_2 0.097 0.543 
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 Q3#1_3 -0.203 0.198 
Q18a: Did you perceive the other staff to 
be interested in your description of your 
situation? 
Q3#1_1 0.255 0.103 
 Q3#1_2 -0.089 0.577 
 Q3#1_3 -0.288 0.065 
Q19a: Did you get enough time to talk 
and interact with the other staff? 
Q3#1_1 0.252 0.113 
 Q3#1_2 -0.092 0.566 
 Q3#1_3 -0.308 0.050 
Q20a: Were you given the necessary 
information about how detoxification 
would be carried out? 
Q3#1_1 0.287 0.065 
 Q3#1_2 0.319 0.040 
 Q3#1_3 -0.136 0.391 
Q21a: Did you get sufficient information 
about your diagnosis? 
Q3#1_1 0.231 0.141 
 Q3#1_2 0.092 0.560 
 Q3#1_3 -0.183 0.247 
Q22a: Did you perceive the treatment 
you received as suited to your situation? 
Q3#1_1 0.099 0.535 
 Q3#1_2 -0.176 0.265 
 Q3#1_3 -0.424 0.005 
Q23a: Were you involved in any decision 
involving your treatment? 
Q3#1_1 0.095 0.549 
 Q3#1_2 -0.175 0.267 
 Q3#1_3 -0.409 0.007 
Q24a: Did you perceive the institution’s 
work as well organized? 
Q3#1_1 0.378 0.013 
 Q3#1_2 -0.026 0.870 
 Q3#1_3 -0.265 0.090 
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Q25a: To what extent did Alaska 
Treatment Center prepare you for 
continuity of care after the 
detoxification? 
Q3#1_1 0.253 0.107 
 Q3#1_2 0.103 0.518 
 Q3#1_3 -0.234 0.135 
Q26a: To what extent did the 
organization work with other facilities to 
ensure your smooth transition to the next 
phase of substance treatment after 
detoxification? 
Q3#1_1 0.253 0.107 
 Q3#1_2 0.103 0.518 
 Q3#1_3 -0.234 0.135 
Q27a: Did you have to wait after your 
initial evaluation to be scheduled for 
detoxification at ATC? 
Q3#1_1 -0.135 0.396 
 Q3#1_2 -0.006 0.969 
 Q3#1_3 -0.071 0.656 
Q28a: Overall, what benefit have you had 
from the care at the institution? 
Q3#1_1 -0.079 0.618 
 Q3#1_2 -0.090 0.570 
 Q3#1_3 -0.436 0.004 
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As an overall scale, items Q10b_A through Q28a showed strong reliability, with a 
Cronbach’s alpha of 0.889.  Using the strength of Spearman’s rho correlations, the survey items 
were used to compute problem scores representing each of the detoxification rating outcomes.  
The “Before” (initial encounter) problem score was computed as the sum of Q14a, Q15a, Q16a, 
Q21a, and Q24a.  The “During” treatment problem score was computed as the sum of Q10b_A, 
Q20a, and Q27a.  The “After” treatment problem score was computed as the sum of Q11a, Q12a, 
Q13a, Q18a, Q19a, Q22a, Q23a, Q25a, Q26a, and Q28a.  Cronbach’s alpha was computed for 
each of these problem scores to assess scale reliability, shown in Table 4.  The reliability of the 
Before and After problem scores were high, while the reliability of the During problem score 
was low.   Analyses comparing the Cronbach’s alpha if one item was deleted from the scale were 
performed for each of the scales, and neither scale (Before and After) showed a significant 
increase in Cronbach’s alpha if any of the items were deleted from those scales.  Since there 
were only three items in the During treatment scale, and none of those items were particularly 
strongly correlated with each other or the outcome they represent, Cronbach’s alpha was always 
low for that scale. 
Table 4 
Cronbach’s Alpha of Problem Scores 
Variable Minimum 
 
Maximum Mean SD Skewness Cronbach’s 
Alpha 
“Before” Problem Score 13 20 18.27 2.19 0.93 0.786 
“During” Problem Score 8 12 10.86 1.30 0.63 0.080 
“After” Problem Score 15 41 37.75 4.86 2.94 0.921 
 
Results showing Spearman’s rho correlations between the problem scores and their 
respective detoxification outcomes are shown in Table 5.  The Before problem score had a 
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significant medium positive correlation with the detoxification rating before treatment, rho = 
0.414, p = .007.  The After problem score had a significant medium correlation with the 
detoxification rating after treatment, rho = 0.439, p = .005.  The correlation of the During 
problem score and the detoxification rating during treatment was weak and not significant, rho = 
0.047, p = .769.   
Table 5 
 Spearman’s Rho of Problem Scores with Detoxification Ratings 
Variable Outcome Spearman’s 
Rho 
p-value 
“Before” Problem Score Q3#1_1 0.414 .007 
“During” Problem Score Q3#1_2 0.047 .769 
“After” Problem Score Q3#1_3 0.439 .005 
 
 
The results in Table 5 should be interpreted with caution.  Due to the small sample size 
used and minimal variability in the survey responses leading to uninformative PCA results, this 
approach was taken out of necessity.  Further study should include running the problem score 
correlations with the detoxification ratings on a new sample to avoid overfitting. 
Discussion 
 There were 17 responses to items Q7 and Q8.  The responses were similar, and address 
issues of location visibility, provider flexibility, onsite lab, trust, additional staff, and schedules.  
The most common issue patients wanted to see resolved was not having enough staff to answer 
their phone calls and attend to them when they needed help.  Other issue is the visibility of the 
treatment center; it is overshadowed by the mortgage company located nearby, and patients have 
difficulty seeing the ATC sign.  Another important result indicated by responses is that patients 
prefer having their laboratory testing performed at ATC rather than being referred to LabCorp, 
which is approximately a 15-minute drive from the ATC location.   
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These responses point to a need for change in the criteria used by ATC to select patients 
for detoxification in an outpatient setting.  The names of other facilities with which the patients 
compared ATC have been removed from all quotations.  Below are unedited quotes from patient 
responses: 
Trust your patients.  I felt you were not going to change your mind about sending me to 
the hospital to detox even though I had insisted I do not want to go to the hospital.  
Refusing us medications when the inpatient detox services you recommended are not 
ready for us is not good. 
Stop telling patients desperate for detox they need to be willing to go for counseling 
services after detox.  I wanted only detox.  I am high functioning person who does not 
need all these years of pitying about my past addiction. 
Be flexible to allow all clients who needs your services. 
Add home treatment, most of us can do well at home going through withdrawal with the 
right guidance. 
Give more suboxone and stop being overly strict with giving the meds, we need those 
meds, that’s why we come to you.  You told me during my first visit that the maximum I 
can get was three per day, but I was never given three strips even when I was screaming 
the pain is too much.  It was a painful treatment but better than first experience at … 
These responses form a basis for building a theoretical and logical model for the ATC 
detox program that addresses and enhances patient experiences and points to the need for 
changes to operations and organizational structure.  The structural change most needed is 
relocating the practice to an easy-to-see but private location, which will require funding.  On 
average, the practice is currently seeing four to six patients per week.  Additional funding 
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sources through either grants or loans will need to be explored to mitigate the issues of 
inadequate staffing and delayed return of phone calls even though this issue was indirectly 
inferred from the responses.  The theoretical framework will focus on improving practitioners’ 
engagement with patients, building trust, and helping patients gain insight into and understand 
their addiction and symptoms.  The overall goal of this model will be to increase patient 
motivation for detoxification adherence and help prevent poor patient experiences at ATC, as 
reflected in the foregoing responses and statement below from a participant response to Item 8: 
 I relapsed four times, and I was refused the opportunity to continue treatment at ATC, I 
was told my situation requires inpatient.  I learned from some friends they relapsed 20 
times and they are still given their medications at …  I think this program is overly strict. 
 The creation and improvement of the logical model require evaluation of the operational 
inputs from the perspective of patient responses.  The ATC model of detoxification currently 
addresses only patients with AUD and OUD; extending the service to patients with dependence 
on methamphetamine and other substances will increase accessibility to more individuals.  A 
biopsychosocial ATC model encompassing treatment for all patients with substance/AUD 
necessitates increasing the number of practitioners and supporting staff.  The hiring of 
specialists, such as chemical dependency staff to perform initial ASAM screening, nurses, and 
medical assistants to facilitate the detoxification processes, counselors, and other supporting 
staff, are key to achieving the outcomes of the logic model.  The current outcomes depicted in 
the logic model reveal the physiological, social, and economic benefits to the individuals, family, 
and community.  The logic model outcomes are evaluated vis-a-vis current Alaska outcome 
measures for OUD/AUD, which illuminate the social determinants of alcohol and substance use 
disorders as remediable through the ATC modified biopsychosocial model of detoxification.  
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The modification of the ATC logic model seeking to include structural and organizational 
operational factors is consistent with the PICO question seeking to utilize the outcome of the 
existing model to develop a more responsive approach to care. 
 The overall results are in agreement with studies supporting outpatient detoxification as 
feasible and cost-effective (Barry et al., 2013; Corace et al., 2019; Deacon et al., 2014; Ho & 
Adcock, 2017; Johnson & Faraone, 2013; Mannelli et al., 2014; Schmidt et al., 2017).  The ATC 
model of outpatient detoxification addresses the feasibility of outpatient detoxification.  Of the 
42 participants, none of the patients reported safety concerns during detoxification, and there was 
a 100% completion rate for detoxification. 
 Two of the interventions encompassing all the items for initial biopsychosocial 
evaluation and continuity of care after detoxification revealed a significant positive correlation 
with after-detoxification results, rho = 0.1414, p = .007, and a significant negative correlation, 
rho = -0.439, p = .769.  The after-detoxification results are consistent with other studies 
reporting a similar rate of completion of outpatient detoxification (70%–100%) and rate of 
continuity of care after detoxification (50%–70%; Acevedo et al., 2016; Barry et al., 2013; 
Bisaga et al., 2018; Brett et al., 2014; Corace et al., 2019; Deacon et al., 2014; Ho & Adcock, 
2017; Nadkarni et al., 2017).  
 The overwhelmingly positive response of patient experience with detoxification and the 
homogeneity of responses contributed to the weak correlation significance, rho = 0.047, p 
= .769.  This is the first project known to evaluate the patient experience during detoxification.  
Although the during-detoxification results lack statistical significance, their clinical relevance 
cannot be ruled out.  The significance of the before-detoxification results could have contributed 
to the homogeneity of the responses during detoxification.  The initial evaluation and its criteria 
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for identifying patients appropriate for outpatient detoxification are the determinants of the 
during detoxification outcomes, which are reflected in the after-detoxification results.  In other 
words, the patient experience during detoxification is partially reliant on the initial evaluation, 
which involves using specific criteria to select the appropriate patients for outpatient 
detoxification.  The patients’ experiences from the data responses show that the criteria were 
accurate in selecting the appropriate patients.  The positive outcomes of those at the borderline of 
exclusion but allowed into the detoxification process pave the way for modifying the criteria to 
extend outpatient detoxification to more patients in the future.  The items in the questionnaire 
highlighted trust, motivation, organization, education, time, care, safety, and accessibility.  Based 
on these critical principles, during detoxification, addressing care, trust, and time was utilized to 
help in developing the theory of change.  The pre and post detoxification items addressing trust, 
motivation, safety, and how organized the institution was used to develop and modify a flow 
chart, decision tree, and logic model.  The decision tree had minor modifications based on item 7 
and 8 quality responses to making it flexible for more patients to have access to outpatient 
detoxification. 
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Chapter 7: DNP Essentials 
The project addressed each DNP essentials from I to VIII. The overarching goal of the 
project was to evaluate the experiences of patients from the designed model of outpatient 
detoxification at ATC, identify innovative practice strategies for improvement of the model, and 
formulate strategic practice advancement using empirical data from participants to improve the 
model for clinical practice (American Association of College of Nursing, 2006).   
DNP Essentials I and II 
DNP Essentials I and II highlight the project's scientific underpinning and organizational 
and systems leadership for quality improvement and systems thinking.  The scientific 
underpinning of addiction disease and detoxification is detailed throughout the project based on 
evidence and a comprehensive description of the biopsychosocial model of detoxification 
(American Association of College of Nursing, 2006).  Thus, the projects' outcome addresses the 
clinical question that seeks to improve the model of detoxification based on patient experiences.  
The focus on ATC demonstrated the organizational and systems leadership for quality 
improvement and system thinking.  The primary investigator started ATC, reflecting NSG 684 
(Organizational Leadership), and hired experts from the health-care industry in the early years of 
operation.  These early actions and the quality improvement implemented recently from the 
outcome of this project attest to his transformational leadership.  The project's outcome leading 
to the modification of the ATC model includes modifying the treatment process for patients and 
organizational systems, such as environment, staffing, and resources that impact patients’ 
experiences.  The ATC start-up and the project undertaking are an accomplishment borne out of 
the DNP essentials that promote the advanced nurse practitioners' autonomy as a full and equal 
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provider in health care and leadership in the health-care organization beyond this project 
(American Association of College of Nursing, 2006). 
 Contextual and conceptual utilization: Theory of change.  The contextual and 
conceptual utilization of the project encompasses DNP Essentials I and II. The ATC 
detoxification model is based on the neurobiology of the brain and science of addiction.  
Although each substance of abuse has specific pathways, established scientific evidence shows 
that when addiction substances reach the brain, the area of action is usually the limbic system, 
also known as the reward center.  ATC interventions' logic is based on the crucial dopaminergic 
receptor pathways from the limbic system, specifically the ventral tegmental, nucleus 
accumbens, and striatum, which are correlated with the frontal cortex (Stahl, 2013).  In other 
words, the dopamine pathway from the limbic system projects to the frontal cortex, and the 
dopamine projections from the frontal cortex must be intact to regulate the reward center.  The 
ventral striatum is associated with impulsive actions that automatically stimulate the human 
system to fulfill physiological needs without the involvement of the frontal cortex, while the 
dorsal striatum is associated with compulsive actions activated to synchronize with the nucleus 
accumbens after repeated use of synthetic substances.  The use of alcohol and opioids changes 
the action potentials that stimulate neurotransmitters' release from pre- to postsynaptic receptors.  
The changes in action potential lead to the fluctuation of receptors as the individual continues to 
require more of the substance to satisfy their insatiable need for dopamine.  This phenomenon is 
called tolerance, which is the underlying reason for addiction and leads to withdrawal, cravings, 
and obsessive thoughts of obtaining the substance by any means (Sadock, Sadock, & Ruiz, 2014; 
Stahl, 2013). 
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   ATC recognizes the complexity of addiction and physiological withdrawal effect 
throughout the body.  Ceasing to use a substance that an individual has built a tolerance for in the 
brain and body increases the risk of fatality and unpleasant physiological effects.  Gradual 
removal of toxins through detoxification is medically necessary to prevent fatality, unpleasant 
physiological effects, and early relapse (ASAM, 2019).  
A central tenant of the ATC model is that detoxification is the first and most fundamental 
phase of successful recovery treatment for individuals who have developed a tolerance for 
opioids and alcohol to the extent that they cannot stop using on their own.  The ATC outpatient 
detoxification model rests on a comprehensive understanding of addiction neurobiology and 
symptomatologic treatment of withdrawal using approved medications.  At the same time, it 
aims to ensure that each component of nonpharmacological interventions addresses the quality of 
care for patients and ultimately enhances the continuity of the recovery process.  The outcome of 
the project based on the patients’ experiences revealed that outpatient detoxification is feasible 
and can be adopted to promote health treatment of alcohol and substance abuse nationwide. 
The theory of change provides strong support for DNP Essentials I and II. The theory of 
change provides the patient with the opportunity to meet practitioners and support staff.  The 
practitioners and support staff work in collaboration to educate patients on withdrawal symptoms 
and the dangers of withdrawal, enhancing the patient's cognitive ability to cope with the 
symptoms in an active way.  
During the patient's withdrawal experience, the practitioner collaborates with the support 
staff to ensure the patient receives appropriate and customized treatment for withdrawal 
symptoms.  
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The timely assessment and administration of medications to prevent withdrawal symptoms allow 
the body to excrete toxins via the sweat glands, lungs, kidneys, and intestines without a traumatic 
effect on the brain and heart.  A continuous, thorough assessment and appropriate administration 
of the correct medications for withdrawal symptoms alleviate symptoms by Day 5, on average.  
The modification includes additional support staff and comfort medications to the FDA approved 
drugs to minimize dysphoric experience expressed during detoxification responses (Q3#1_2, Q7, 
Q8) and shown in the decision tree.  This modification from during detoxification experiences 
aligns with the DNP essential on clinical scholarship and promoting nationwide health care 
(American Association College of Nursing, 2006). 
After withdrawal, the next goal is to ensure the patient will succeed in the continuity of 
care recovery process.  This is the final step in the detoxification process and focuses on re-
evaluating the patient for their readiness to transition into individual therapy, group counseling, 
and support groups.  The practitioner assesses and educates the patient about maintenance phase 
medications and transition into individual and group therapy.  The four crucial areas of 
assessment are the patient's motivation to continue care and emotionally self-regulate and their 
cognitive flexibility and physical readiness to start perceiving themselves as a nonuser who 
needs to continue the use of counseling services and support groups as part of their journey 
toward recovery.  The after-detoxification evaluation and continuity of care involve counseling 
services to educate the patient to think differently and redefine themselves not by their disease of 
addiction but their role in society and sense of human dignity and purpose (American 
Association College of Nursing, 2006). 
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DNP Essentials III and IV 
Flow chart and decision tree (algorithm for detoxification).  DNP Essentials III and 
IV cover the clinical scholarship and analytical methods for evidence-based practice, including 
patient care and informational systems/technology and to improve and transform health care 
(American Association of College of Nursing, 2006).  The primary investigator's continuous 
research and practice is a bridge for this project and directs to the DNP essential at clinical 
scholarship and analytical methods for evidence-based practice.  Integrating the ATC 
biopsychosocial model of detoxification into the electronic records and policy of ATC reflects 
the following DNP essential: informational systems/technology and patient-care technology for 
improvement and transformation of health care and health-care policy for advocacy in health 
care. 
 DNP Essentials III and IV encapsulate the outcome modification of the system flow chart 
(Figure 1) and decision tree (Figure 2).  Outpatient detoxification can be done either in the 
patient's home or at a practitioner's office.  The ATC performs the majority of office-based 
detoxification, with a few at-home detoxifications, and follows a biopsychosocial model of 
detoxification encompassing physiological, psychological, and social determinants.  The 
detoxification model at ATC has three stages: evaluation, detoxification, and readiness for the 
next phase of substance treatment, which linearly responds to Kurt Lewin’s organizational 
change framework.  The first stage requires a full psychiatric, medical, and ASAM chemical 
dependency assessment.  Based on the evaluation, a diagnosis of AUD and/or OUD with relevant 
specifications is made.  Evaluation of patients’ past and current medical conditions is crucial in 
determining eligibility.  Laboratory tests and screenings are done to determine medical 
conditions, psychiatric disorders, and the impact of substance use on the individual.  During this 
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initial evaluation, patients are provided with information about enrollment in or continuation of 
counseling and support groups after detoxification (American Association College of Nursing, 
2006). 
 The evaluation categorizes patients according to inclusion and exclusion criteria.  The 
inclusion criteria are moderate AUD/OUD dependency, history of moderate withdrawal, 
frequency of use greater or equal to every 4 hours, common psychiatric disorders with moderate 
severity, and social determinants.  The exclusion criteria are pregnant women undergoing alcohol 
or opioid withdrawal, unmanaged diabetes with A1C >12 mg/dl and/or hypertension with BP 
>160/100, severe somatic disorders, history of epilepsy, history of delirium tremors, acute mania, 
severe psychosis, severe panic attacks, history of late Alzheimer’s with AUD/OUD, unresolved 
traumatic brain history with AUD, history of conversion disorder, and the social factors of living 
alone and having no support person (Kamal et al., 2014).  The inclusion and exclusion criteria 
are a crucial aspect of the decision tree for selecting patients for outpatient detoxification. 
 Once an individual is determined eligible for outpatient detoxification and expresses the 
willingness to participate then education and resources about detoxification are provided to the 
patient.  A support person accompanies the patient with AUD to the clinic 1 hour before they 
experience withdrawal symptoms.  The patient brings their own food to the clinic.  The CIWA 
protocol is applied to assess and manage the patient using approved medications for 
detoxification.  Patients are usually discharged to return home after 4 to 6 hours of 
detoxification, showing a consistent CIWA score below 8 for at least 2 hours.  The patient 
returns to the clinic the following morning to undergo the CIWA protocol process (U.S. 
Department of Health and Human Services, National Institute of Mental Health, and Substance 
Abuse and Mental Health Administration, 2019).  
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The patient with OUD arrives at the clinic in a state of mild to moderate withdrawal.  The COW 
protocol is used to assess and manage the patient using approved medications.  The patients are 
usually discharged home after consistent COW scores below 6 for 2 hours.   
 Detoxification at the stabilization stage is determined successful when the AUD patient's 
CIWA score consistently stays below 8 for 2 days, and the OUD patient’s COW score remains 
consistently below 6 for 2 days.  The use of FDA-approved medications for this stage of 
detoxification is essential for an optimal outcome (U.S. Department of Health and Human 
Services, National Institute of Mental Health, and Substance Abuse and Mental Health 
Administration, 2019). 
           Assessment of readiness to continue to the next phase of substance treatment is vital to a 
patient's recovery because detoxification is not substance treatment; it is a principal foundation 
for successful substance treatment.  Education and resources are provided to patients on 
maintenance drugs, individual therapy, and group therapy.  Some patients elect to receive only 
maintenance drugs monthly or daily for AUD or biweekly to monthly for OUD.  Most patients 
receive maintenance drugs and continue counseling and behavioral modifications through group 
and individual therapy (U.S. Department of Health and Human Services, National Institute of 
Mental Health, and Substance Abuse and Mental Health Administration, 2019). 
  Numerous studies have reported that post-acute withdrawal symptoms, such as 
depression, anxiety, insomnia, and negative alterations in emotions, linger for a substantial 
period after detoxification (Bondi, 2016; Economidou et al., 2011; Heilig et al., 2010).  
Implementing a relapse prevention plan has been a strong predictor of long-term recovery.  The 
modified ATC model based on the significant findings of after treatment (rho = 0.439, p = 0.005) 
integrates relapse prevention strategies that include assessment of physical, social, and 
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psychological factors that will contribute to post-acute withdrawal symptoms, identification of 
triggers, plan development, and the signing of a contract providing for referral to long-term 
inpatient treatment if the patient relapses more than three times within 1 year of detoxification.  
The prevention and management of post-acute withdrawal symptoms are revisited and 
emphasized after stabilization when the patient is cleared to start pharmacological maintenance 
therapy.  Following this process will address some of the concerns expressed by participants 
indicated in Q7 and Q8. 
  Based on the project's findings, the ATC model modifies the decision tree to facilitate the 
appropriate responses of patients to care as indicated in the PICO.  Development of the flow 
chart into the electronic system to improve the during treatment aspect based on a weak and 
insignificant result of the findings, rho = 0.047, p = .769, translates into the DNP essential for the 
clinical scholarship and analytical method for evidence-based practice including the utilization of 
information technology.  This aspect of the project is a critical clinical analysis of the before-
treatment responses, which inevitably reflects the patients' experiences during detoxification but 
shows low statistical significance because of inadequate variability (American Association 
College of Nursing, 2006). 
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medication. 
Relapse (Within 14 days of 
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detoxification.  
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single year. More than three 
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contract for referral to inpatient 
rehabilitation after next 
stabilization. Figure 1. Alaska Treatment Center model flow chart. 
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Figure 2.  
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DNP Essentials V and VI 
Health-care policy for advocacy in health care and interprofessional collaboration for 
improving patient and population health outcomes represents DNP Essentials V and VI, 
respectively (American Association of College of Nursing, 2006).  This project led to building a 
new network and collaborating with different disciplines to ensure the quality of care for patients 
who undergo outpatient detoxification at ATC.  The interprofessional team include a family 
nurse practitioner, psychiatric nurse practitioner, behavioral medicine physician, and a Ph.D. 
prepared psychologist.  
  The project's findings led to bringing other experts onboard and a potential collaboration 
with Providence Family Medicine to consider starting a fellowship in addiction medicine that 
will train medical and nurse practitioners interested in outpatient detoxification to provide quality 
care for individuals diagnosed with the disease of addiction (American Association College of 
Nursing, 2006).  
 Limiting DNP Essential VI (Interprofessional collaboration for improving patient and 
population health outcomes) solely to the DNP project period will rule out what the DNP 
programs prepare graduates to accomplish in this area.  The program's organizational leadership 
component provided the opportunity to explore entrepreneurship and leadership skills through 
interprofessional collaboration to accomplish the Institute of Medicine's (IOM) mandate in a 
safe, timely, effective, efficient, equitable, and patient-centered care in a complex environment.  
The platform to accomplish these mandates has been created through interprofessional 
collaboration with the School of Social Work and Human Services that led to a SAMSHA grant 
of $250,000 to develop and promote substance abuse education in Alaska.  Supporting the 
SAMSHA grant's work with outcomes of this project will enhance the consultative and 
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leadership skills of the intra- and interprofessional teams so they may create change in the 
promotion of alcohol and substance abuse education and treatment (American Association 
College of Nursing, 2006). 
According to the IOM Committee on Quality of Health Care in America (2001), which 
serves as the foundation for the DNP essential on health-care policy, the graduate is expected to 
design, implement, and influence health-care policies defining financing, practice regulation, 
access, safety, quality, and efficacy.  This project implementation addressed the practice 
regulation, quality, and efficacy revealing data that shows areas where ATC provides quality of 
care and areas needing organizational change.  Identifying the strategic improvement areas that 
led to the biopsychosocial detoxification model's modifications provides the opportunity to 
address access, safety, and financing in outpatient detoxification (IOM Committee on Quality of 
Health Care in America, 2001).  
DNP Essentials VII and VIII 
 Essential VII refers to clinical prevention and population health for improving the 
nation’s health.  Outpatient detoxification is a secondary preventative service that saves patients 
from fatality and recidivism and enhances relapse prevention through continuity of care.  The 
data collection and analysis of the data from participants who underwent outpatient 
detoxification supports the transformation of alcohol and opioid treatment in outpatient settings.  
A promotion of outpatient detoxification resulting from this project contributes to reducing 
fatality from OUD and AUD.  A comprehensive strategic improvement area determined from the 
data analyses led to the modification of the biopsychosocial model and the logic model that 
provided futuristic insight based on the ATC impacts on individuals struggling with the disease 
of addiction who underwent detoxification.  A detail of the logic model aligning with DNP 
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Essential VII is detailed in the implication and empirical analysis (American Association of 
College of Nursing, 2006).  
 DNP Essential VIII refers to advanced nursing practice.  Essential VIII is threaded 
throughout the entire DNP program.  The nursing practice's project advancement encompasses 
all the seven objectives for a graduate DNP program under Essential VIII. This project's most 
unique accomplishment in advancing nursing practice is that it introduces specialty focus: 
addiction medicine missing in graduate nurse practitioner programs; although some nurse 
practitioners have waivers to prescribe Suboxone for patients with OUD.  There is inadequate 
knowledge in providing quality addiction treatment for patients.  This lack of education 
continues to increase opioid and benzodiazepine prescription among providers without training 
in the fundamentals of addiction medicine.  The designing of the components of the 
biopsychosocial model (i.e., flow chart, theory of change, and logic model) illustrate the 
advanced nursing practice knowledge and analytical skills in implementing change in the 
organization, administration, and education (Ho & Adcock, 2017).  The dissemination of this 
project to MAT and primary health-care centers will continue to advance nursing practice in 
addiction medicine (American Association of College of Nursing, 2006).     
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Figure 3. Theory of change for the Alaska Treatment Center Outpatient Detoxification Program/Outcome A. 
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Figure 4. Theory of change for the Alaska Treatment Center Outpatient Detoxification Program/Outcome B. 
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Implications and Empirical Analysis: The ATC Logic Model   
DNP Essential VII (clinical prevention and population health for improving the nation’s 
health) is echoed throughout the project but more so in the implication and empirical analysis of 
the ATC logic model (American Association of College of Nursing, 2006).  The design of the 
logic model encompasses health promotion and risk reduction deduced from the outcomes of the 
biopsychosocial model of detoxification.  The logic model of the ATC is an overview of the 
problem, available resources, operational activities, outcomes, outcome measures, and impact on 
the individual, family, and community.  The different areas of specialty of the three ATC 
practitioners address the biopsychosocial needs of the patients.  Other specialty clinics in the 
community refer their patients to ATC mainly for substance treatment.  The Narcotic Drug 
Treatment Center of Anchorage refers most of its patients to ATC for biopsychosocial evaluation 
and management.  The key activities of the model flow in a linear chronological manner are 
initial evaluation, treatment of withdrawal symptoms, and promotion of continuity of care.  The 
patient's underlying mental health, medical, family, and relationship issues are also addressed.  
The linear flow of care seeks to follow variables from the initial evaluation to after 
detoxification.  A revised clinical question for the findings in this project would be, “Do the 
experiences of patients in the initial evaluation influence the outcome of detoxification and 
continuity of care?” 
 The observed outcomes of ATC’s holistic approach to patient care are stabilization, 
improvement in emotional regulation, involvement in productive activity, housing stabilization, 
gaining a driver’s license, increased job placement, reduction in suicide, and reduction in 
accidental death from drug and/or alcohol use.  The most apparent impacts of the ATC model of 
detoxification are the ripple effects of treatment experienced by the patient's family and 
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consistent referrals from the community by word of mouth.  These impacts are particularly 
significant given the prevalence of opioid and alcohol abuse in the state of Alaska. 
 The ATC model of treatment has significantly impacted patients.  Of the 42 participants, 40 
responded that their goals had been met and that they were satisfied with their experience at 
ATC.  We have seen reduced recidivism in patients who underwent detoxification compared to 
those who did not, many individuals are still attending counseling services, and most have joined 
a support group. 
 The sustainability of the ATC model of detoxification focuses on the why of outpatient 
detoxification, followed by the what and how.  A leadership presentation on why some 
organizations excel pointed out that organizations that are successful in a turbulent market are 
not solely data- or outcome-driven but share a belief or dream with their customers (Sinek, 
2004).  ATC believes that outpatient detoxification is feasible, safe, and affordable, a vision 
shared by most of its customers (patients).  Investigating the experiences of these customers 
buttresses the biopsychosocial model of outpatient detoxification and provides the necessary 
support for sustainability.  The flow chart, theory of change, and logic model derived from the 
outcomes of the project implementation are means of ensuring a sustainable future for the ATC 
model of outpatient detoxification.  The logic model extrapolates from the design of the aims of 
the project outcomes in Chapter 1, specifically Aim 4: “What characteristics of the population 
and their addiction history correlates with patient-centered outcomes of care, satisfaction, and 
quality?”  This is evidenced by the features of the before and after detox from the project 
implementation; however, the inferences from the before, during, and after detoxification to 
modifying the biopsychosocial model are the vehicles for sustainability.
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Implications for Clinical Practice 
The ATC biopsychosocial model of outpatient detoxification data analysis highlights five 
strategic pathways to implement change at the organization.  These strategic pathways are 
theoretical, systematic, conceptual, contextual, implementational, and empirical analysis.  The 
flow chart, decision tree, change theory, and logic model—with their key concepts, including the 
implementation and empirical analyses—provide clinical relevance to the clinical question of the 
project: What are the substantive improvements the practitioner evaluator can make to an 
existing model of outpatient detoxification to develop a more patient-responsive approach to 
care?  
The expected outcome from the PICO was an improved intervention model for outpatient 
detoxification at ATC.  The approach used in this project responded to all the subquestions in the 
clinical inquiry.  The subquestion for clinical inquiry 5.  What factors of the patient experience 
are predictive of patient-centered outcomes, satisfaction, and quality of care?  The data analyzed 
from these items provided a clinically relevant tool in developing a logic model as part of the 
improved intervention model for ATC outpatient detoxification.  The logic model will provide 
concrete and measurable outcomes when utilized with the biopsychosocial model of 
detoxification.  
 Although the project revealed limitations, such as a small sample size and lack of 
variations in data responses, the patients’ responses were generally positive regarding the 
services they received at ATC.  Implementation analysis revealed that the services are clinically 
relevant to patients based on the positive responses from the 42 participants.  Further, all 
responses of Q7 and Q8 substantiate the utilization of the applied criteria for selecting 
appropriate patients for outpatient detoxification.   
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The overwhelmingly positive homogeneity of the patient experiences during 
detoxification is attributable to the fact that the initial evaluation successfully selected patients 
who were eligible for outpatient detoxification based on the inclusive criteria posited by the 
project from ASAM criteria and DSM-V.  The strategic modification of the ATC model of 
outpatient detoxification from this project led to the designing of a flow chart, decision tree, 
theory of change, and logic model to improve clinical practice at the ATC and other addiction 
treatment facilities and provide education to addiction practitioners.  ATC practitioners will find 
detoxification easy to implement using this flow chart, decision tree, and model.  MAT 
programs, primary health-care facilities, and other addiction treatment programs will benefit 
from the ATC biopsychosocial model, as will nurse practitioners, physician assistants, and 
medical doctors interested in the treatment of addiction.  The decision tree, for instance, provides 
the practitioner with a quick guide to the process of detoxification, including specific 
pharmacology that should be considered.  
Limitations 
 The theoretical framework and logic model evaluation propose different metrics of the 
patient experience.  The results of the analysis of the short generic questionnaire revealed 
limitations in the instrument for evaluating patient experiences in outpatient detoxification.  The 
items lack variation, which is reflected in the responses and correlation analysis of the data.  
Although the response rate was 84%, which was greater than the expected response rate of 75%, 
the instrument and method used for the project require a larger sample size.  The sample size 
from this project was too small to draw general conclusions regarding clinical relevance.  
Designing a new instrument that incorporates sufficient variations into the assessment of 
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patients’ detoxification experiences is needed.  Future studies should focus on designing an 
instrument that generates variation in patient responses.  
Also, this project focused solely on patients with AUD and/or OUD, while a wide variety 
of substance use disorders exists, which future studies should consider.  Future studies should 
consider examining the outcome variables extrapolated from the logic model, which is beyond 
this project, to determine the predictive variables for preventing relapse after detoxification and 
during the continuity of care. 
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Chapter 8: Summary & Conclusion 
The introduction of the MAT program by the SAMHSA with the support of federal 
administration-approved medications, including counseling and behavior services, is aimed at 
reducing AUD/OUD across the nation.  Anchorage is among the cities across the nation besieged 
by the alcohol and opioid crisis.  The city has numerous outpatient MAT programs and 
outpatient substance treatment settings that could provide more outpatient detoxification 
programs.  Although the literature supports outpatient detoxification as feasible, safe, and 
affordable, it does not provide a specific outpatient detoxification model.  ATC, located in the 
heart of the city, is the only treatment center that offers outpatient detoxification based on the 
biopsychosocial model of detoxification.  Since the ATC model of outpatient detoxification 
seeks to expand treatment through this model, it is necessary to evaluate the patients’ 
experiences to improve clinical practice at ATC and substance treatment. 
Project Goals 
The overarching goal of the project was to evaluate the experiences of patients from the 
designed model of outpatient detoxification at ATC, identify innovative practice strategies for 
improvement of the model, and formulate strategic practice advancement using empirical data 
from participants to improve the model for clinical practice.  The goal epitomizes a discovery in 
action from the Boyer model of scholarship, in which the search for new knowledge starts with a 
purpose for that knowledge, a purpose that will address problems, aid society, and brings system 
change to an organization (Boyer et al., 2015). 
Methods 
Descriptive statistics of demographic and survey responses were presented using 
frequencies and percentages for categorical and ordinal variables.  Measures of central tendency, 
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including mean, median, standard deviation, and skewness of each of the survey items were 
examined.  The 45 survey items were condensed into three areas: the initial encounter, the 
relationship during treatment, and overall impression.  Cronbach's alpha coefficient was 
estimated to test the internal consistency of the instrument, and construct validity was evaluated 
using Spearman's rank correlation.  Statistical significance was set at p ≤ .05.  All analyses were 
conducted using SPS version 26. 
Implementation & Resources Utilized 
  The Generic Short Patient Experiences Questionnaire was modified and approved for use 
in this project by the UAA IRB.  The survey instrument was administered to 42 participants who 
received outpatient detoxification from ATC and had accepted to participate in the project via 
email.  The findings revealed 100% successful completion rate of detoxification, with a 
significant correlation between before detoxification, rho = 0.1414, p = .007, and after 
detoxification, rho = -0.439, p = .769.   
Significance of Results 
The results from the project revealed a variety of experiences of patients who underwent 
outpatient detoxification at ATC have some similarities and differences.  The similarities are 
consistent with the participants’ responses to the before and after treatment experience.  The 
before and after treatment variables revealed that the model utilized needed some modifications 
and that the majority of patients had a positive experience and would like to see services 
expanded to other patients.  
 The during detoxification experiences responses show treatment was safe and effective for 
patients.  The project encapsulates the four stages of the Boyer model of scholarship.  A 
comprehensive literature review was done to guide the project's purpose, design, and 
DocuSign Envelope ID: A8697833-AD7A-40DE-B71F-3A09BB6A364C
EVALUATING THE PATIENT EXPERIENCE IN OUTPATIENT    80 
implementation, and discoveries from the results led to modifications of the ATC model of 
detoxification.  
The literature provided a comprehensive interpretation of knowledge in outpatient 
detoxification of alcohol and substance abuse and the general substance treatment of patients 
who struggle with addiction and other comorbidities.  The project is pragmatic—the 
modification of the biopsychosocial detoxification is being implemented at ATC to provide 
quality care for individuals struggling with alcohol and substance use disorder.  The application 
of the implementation of the project's outcomes is expanding the clinic and it is growing at a 
more rapid rate than anticipated.  ATC has started accepting students interested in addiction 
medicine to intern at the clinic.  The teaching aspect of Boyer's model of scholarship is 
highlighted in the overarching goal of the project, as it contributes to advancing nurse 
practitioners’ practice and education.  The ATC biopsychosocial model modification materials 
allow for future project to test the materials and continue to use them to enhance patient 
experiences for detoxification. 
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Reflection 
 The DNP project undertaken for the past 2 years involved several didactic courses and 
clinical practicum.  In this section, I reflect on my experiences throughout the program and 
highlight the essentials of the DNP outcomes illuminated in the project: Evaluating the Patient 
Experience in Outpatient Detoxification: Implications for Improvement of the Early Stages of 
Alcohol and/or Opioid Use Disorder and Recovery Treatment Process.  The impact of the project 
on both patients and practice will be reflected upon below. 
Professional Body of Knowledge 
           Like other education, the benefits, even if not apparent immediately, eventually manifest 
in the student's career path.  The DNP curriculum has added to my career as an academic and 
psychiatric nurse practitioner.  Pursuing the DNP led to growth in areas of interest in research 
and practice.  My interest in addiction medicine was enhanced through some of the DNP courses 
that focus on organizational leadership.  ATC, a dual outpatient treatment clinic, is a product of 
the DNP curriculum.  I currently have some articles under journal review that emanated from the 
DNP curriculum. 
The DNP curriculum has contributed to my clinical practice but did not reframe my 
thinking about clinical practice.  The curriculum contributed immensely to how I use evidence-
based resources in practice—the opportunity to seek grants to promote research utilization in 
areas of interest and quality patient care. 
A Summary of the Project and Collegial Relationship 
 The DNP project focused on evaluating the patient experience in an outpatient treatment 
program.  This was a retrospective data collection of the patients who underwent detoxification 
at ATC.  The project's purpose included collecting data, identifying strategies from the 
DocuSign Envelope ID: A8697833-AD7A-40DE-B71F-3A09BB6A364C
EVALUATING THE PATIENT EXPERIENCE IN OUTPATIENT    82 
improvement of the model that was used to detoxify patients, and formulating strategic 
advancement using empirical data from the participants to improve the model for clinical 
practice.  Descriptive statistics of demographic and survey responses were presented using 
frequencies and percentages for categorical and ordinal variables.  The survey instrument was 
administered to 42 participants who received outpatient detoxification from ATC.  Analyses of 
the data revealed 100% successful completion of the detoxification, a significant correlation of 
the before detox, rho = 0.1414, p = .007, and after detoxification, rho = 0.439, p = .769. 
  My committee chair, Dr. Burdette-Taylor, and members, Dr. David Moxley and Dr. 
Kristerra Yawea, contributed in diverse ways to this project's success through their guidance and 
support.  My clinical counterpart, Mr. Kevin Barrette, provided the support letter and the staff to 
facilitate the IRB requirement and the project implementation at ATC.  
Dr. Burdette-Taylor edited and guided in many areas.  Dr. Yawea also edited and guided in many 
areas.  Dr. Moxley guided in designing the project, giving feedback, and meeting every Monday 
evening to evaluate and provide guidance.  He played a vital role in evaluating the statistical 
analysis to ensure the chosen method was the most appropriate.  Dr. Moxley orchestrated ATC 
networking with Providence Breakthrough Bridge Program director Dr. Ryan Wallace, who 
plans to implement an addiction fellow program and collaborate with ATC’s expertise. The 
network with Dr. Wallace offers the opportunity to collaborate with a physician who has 
expertise in addiction medicine in Alaska.  Lastly, the DNP course professor's feedback for NSG 
696C has helped put the finishing touches on the project. 
Outcomes and DNP Essentials 
 DNP Essentials I to VIII were integral and foundational to the DNP project.  DNP 
Essential I (scientific underpinning for practice) illustrates how the biopsychosocial model of 
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detoxification was modified at ATC based on the project's outcome.  DNP Essentials II and III 
highlight the strategic improvement of detoxification by designing the flow chart, theory of 
change, and utilize a logic model for improving organizational and system leadership and based 
on clinical scholarship and an analytical method for evidence practice.  The incorporation of the 
biopsychosocial model into the ATC electronic medical record, ICAnotes, and into the policies 
and procedures of ATC detoxification are outcomes of DNP Essentials IV and V.  DNP Essential 
VI is represented in the continued expansion of ATC and collaboration with JT Morgan 
Counseling Services, Arctic Recovery, Dena A Coy Rehabilitation, and Providence Family 
Medicine Breakthrough Bridge Program.  DNP Essential VII is also aligned with the outcome 
logic model development, which postulates how recovery and prevention of relapses through 
detoxification will improve population health.  DNP Essential VIII encapsulates the project's 
overarching goal by advancing nursing practice to promotes quality of care and disseminates 
findings to other providers.  The DNP project and the course on organizational leadership and 
system thinking were essential in propelling entrepreneurship in the health-care industry. 
Perception of the DNP Degree 
           I conducted and published some research work before enrolling in the DNP program.  I 
initially wanted to pursue a Ph.D. in clinical pharmacology, but schools of interest required being 
on campus.  As a result, I decided to pursue the DNP degree because I realized genetics and 
pharmacology courses are included in the DNP curriculum.  My thought at the beginning was 
that it would be a highly clinical focus program in genetics, pharmacology, and other innovative 
treatments in medicine.  It was a challenge because it requires faculty equipped in those areas. 
Within the last 2 years, the faculty turnover rate created an overly challenging goal.  My current 
view of the DNP degree is the utilization of research for clinical practice improvement. 
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Conclusion 
Evaluating the experience of patients who underwent outpatient detoxification provided 
the opportunity to examine the current model.  The results of the implementation illustrate DNP 
Essentials I to VIII.  The implication of the outcomes cannot be overemphasized for the 
promotion of quality patient care at ATC.  The project has led to a modification of the model 
concerning the prevention of recidivism and management of relapse as a crucial component of 
substance use disorder/AUD treatment, which is an underpinning essential of the DNP.  Each of 
the modifications of the model based on patient experiences correlates with the scientific 
underpinning of practice, organizational systems leadership for quality improvement and systems 
thinking, clinical scholarship and analytical methods for evidence-based practice, informational 
systems/technology, and patient-care technology for the improvement and transformation of 
health care, health-care policy for advocacy in health care, interprofessional collaboration for 
improving patient and population health outcomes, clinical prevention and population health for 
improving the nation’s health, and advancing nursing practice. 
The mining and analysis of the data from the project implementation led to a 
modification of the ATC biopsychosocial model to encompass theoretical, contextual, 
conceptual, systematic, empirical, and implementational analysis.  The strategic areas of 
improvement needed yielded the flow chart, modified decision tree, theory of change, and logic 
model, which are integrated into ATC policies and electronic medical record.  Organizational 
changes such as hiring additional staff and sharing the model with other MAT programs are still 
in progress.  Overall, the project revealed that detoxification is a vital step in substance treatment 
and may be successfully provided in outpatient treatment settings using the right model of 
treatment.  
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Appendix A  
The Generic Questionnaire and Experiences (GS-PEQ)  






2. Did you have any of the following underlying conditions: 
☐Major depressive disorder in full or partial remission 
☐Anxiety disorder in full or partial remission 
☐Type 2 diabetes with A1C <12 
☐Hypertension with BP <140/90 
☐None 
☐Other.  If other, please indicate  
 
3. How would you rate the satisfaction of the following aspect of detoxification received from 
Alaska Treatment Center? 
 
 Very 
Satisfied   
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☐60 and above 
 
7. In your own words how would you describe your detoxification experience at Alaska 
Treatment Center? 
 




9. How can we improve the quality of detoxification we offer? 
 
10a. Did the clinicians talk to you in a way that was easy to understand? 
☐Not at all 
☐ To a small extent 
☐To moderate extent 
☐ To a large extent  
 10b. How important was this to you? 
☐Not important 
☐A little important  
☐Important 
☐Very important 
☐Of utmost importance 
 
11a. Do you have confidence in the clinician’s professional competence? 
 ☐Not at all 
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☐To a small extent  
☐To a moderate extent 
☐To a large extent  
☐Not applicable 
  
11b. How important was this to you? 
 ☐Not important 
 ☐A little important 
 ☐Important 
 ☐Very important  
☐Of utmost importance 
 
12a. To what degree did you perceive that the clinicians cared about you? 
☐Not at all 
☐To a small extent  
☐To a moderate extent  
☐To a large extent 
 
12b. How important was this to you? 
 ☐Not important 
 ☐A little important 
☐Important 
 ☐Very important  
☐Of utmost importance 
 
13a. Did you get enough time to talk and interact with the clinicians? 
☐Not at all 
☐To a small extent  
☐To a moderate extent 
☐To a large extent 
 
13b. How important was this to you? 
 ☐Not important 
☐A little important 
☐Important 
☐Very important  
☐Of utmost importance 
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14a. Did the other staff talk to you in a way that was easy to understand? 
☐Not at all  
☐To a small extent 
☐To a moderate extent  
☐To a large extent  
 
14b. How important was this to you? 
 ☐Not important  
☐A little important 
☐Important  
☐Very important 
 ☐Of utmost importance 
 
15a. Do you have confidence in the other staff’s professional skills? 
☐Not at all  
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
  
15b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐ Very important 
☐Of utmost importance 
 
16a. To what degree did you perceive that the other staff cared about you?  
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
16b. How important was this to you? 
☐Not important 
☐ A little important 
☐Important 
☐Very important 
☐Of utmost importance 
 
17a. To what degree did you perceive that the other staff cared about you? 
☐Not at all 
☐To a small extent 
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☐To a moderate extent 
☐To a large extent 
 
17b. How important was this to you? 
☐Not important 
 ☐A little important 
 ☐Important 
☐Very important 
☐Of utmost importance 
 
18a. Did you perceive the other staff to be interested in your description of your situation? 
☐Not at all 
 ☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
18b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important 
☐Of utmost importance 
 
19a. Did you get enough time to talk and interact with the other staff? 
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
19b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important 
☐Of utmost importance 
 
20a. Were you given the necessary information about how detoxification would be carried out?  
☐Not at all 
☐To a small extent 
 ☐To a moderate extent 
☐To a large extent 
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20b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important 
☐Of utmost importance 
 
21a. Did you get sufficient information about your diagnosis? 
☐Not at all 
☐To a small extent 
 ☐To a moderate extent 
 ☐To a large extent 
 
21b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important 
☐Of utmost importance 
 
22a. Did you perceive the treatment you received as suited to your situation? 
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
22b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important 
 ☐Of utmost importance 
 
23a. Were you involved in any decisions regarding your treatment? 
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
23b. How important was this to you? 
☐Not important 
☐A little important 
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☐Important 
☐Very important 
☐Of utmost importance 
 
24a. Did you perceive the institution’s work as well organized? 
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
24b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important  
☐Of utmost importance 
 
25a. To what extent did Alaska Treatment Center prepare you for continuity of care after the 
detoxification?   
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
25b. How important was this to you? 
☐Not important 
☐ A little important 
☐ Important 
☐Very important 
☐Of utmost importance 
 
26a. To what extent did the organization work with other facilities to ensure your smooth 
transition to the next phase of substance treatment after detoxification?  
☐Not at all 
☐To a small extent 
☐To a moderate extent 
☐To a large extent 
 
26b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
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☐Very important 
☐Of utmost importance 
 
27a. Did you have to wait after your initial evaluation to be scheduled for detoxification at 
Alaska Treatment Center? 
☐No 
☐Yes, but not long.   
☐Yes, quite long. 
☐Yes, much too long 
 
27b. How important was this to you? 
☐Not important 
☐A little important 
☐Important 
☐Very important 
☐Of utmost importance 
 
28a. Overall, what benefit have you had from the care at the institution? 
☐No benefit  
☐Small benefit  
☐Some benefit  
☐Great benefit  
☐Huge benefit  
 
28b. How important was this to you? 
☐Not important 
☐A little important  
☐Important 
☐Very important 
☐Of utmost importance 
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Appendix B  
Synthesis of Evidence 
Author/Date Setting/type of 
substance use 
Disorder 




















N/A 80% of patients 
who received 
detoxification 




21% lower rate of 
relapsing compared 












had lower hazard 
(hazard ratio = 
0.87, p < .01).  


































N/A 56% continue care 
after induction. 
Heroin users had a 
high risk of 
relapsing (HR 1.81)  
compared to opioid 
prescription users 
during the 7-day 
transition.  




similar in all 
groups. 
The NTX/BUP 
(n = 126) rate 
was 34.9%. 
NTX/PBO-B (n 








90% of patients. 1 A 












80% continued care. 
 
8.11% reduction in 
total number of 
alcohol-related ED 
visits. 
82% reduction ED 
revisits in one 
month (p < .001). 
Significant 
reduction in alcohol 
use, depression, and 
No risk reported. 
95% of patients 
reported their 
needs were met. 
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anxiety from clients 
(p < .001). 
 
Deacon, Hines, 


















data was given 
to support the 
claim. 




76% of those older 
than 35 years 
completed 
compared to 50% of 
those below age 35. 












Detoxification N/A Two studies 
reported no 
difference in the 
number of patients 
that continue care 
after detoxification. 
 
The remaining three 
studies did not 
address this 
outcome. 
The rate of 
completion of 
detoxification in 




The four clinical 
trials reported no 














above 90% and 














N/A 90% of the patients 
continue 
psychotherapy.  















































leaving the clinic 











Detoxification N/A Continuity of care 
81% outpatient, 
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Detoxification N/A 50% for the 
outpatient group,  




group: 14.3% (data 
from 1 RCT; 




45% good outcome, 
17% improved, 
28% unimproved, 
10% unknown.  
 
Inpatient group: 
31% good outcome, 
3% improved, 44% 
unimproved, 19% 
unknown, 3% dead. 
Suicidal ideation: 




No difference in 


















N/A N/A Participants had 
significant 
reduction of opioids 
in urine during 
buprenorphine 
induction (OR = 
0.73, p = .004). 
Mild 
nausea/vomiting 
(n = 3), sleep 
disturbance n = 
2) increase 
sweating (n = 1) 
tense muscle (n = 
1). 
The completion 
rate was similar 
for both 
treatment 
gabapentin (n = 
10) and 
placebo (n =11). 
I B 
Schmidt  






Detoxification N/A Of 25,354 patients, 







lower odds of 2-
year mortality (p < 
.0001 for all). 











AUD: Alcohol Use Disorder, OUD: Opioid Use Disorder, NTX/BUP: Naltrexone/Buprenorphine, NTX/PBO-BP: Naltrexone/Placebo-Buprenorphine, PBO-N/PBO-B: Placebo-Naltrexone/Placebo-
Buprenorphine 
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Appendix C  
Description of the Detoxification Model 
Outpatient detoxification can be done in either of these settings: the patient’s home and the practitioner’s office.  
Alaska Treatment Center (ATC) performs mostly office-based detoxification and few home detoxifications.  ATC 
has a biopsychosocial model of detoxification.  The biopsychosocial model encompasses physiological, 
psychological, and social determinants.    
 
The detoxification model at Alaska Treatment Center has three stages.  The stages are evaluation, stabilization, and 
readiness for the next phase of substance treatment.  The first stage requires a full psychiatric, medical, and ASAM 
chemical dependency assessment.  Based on the evaluation diagnosis of alcohol use disorder (AUD) and/or opioid 
use disorder (OUD) and its specificity is made.  The evaluation of the patient’s past and current medical conditions 
is crucial to determining eligibility.  Laboratory tests and screens are done to rule in and out the medical conditions, 
psychiatric disorders, and the impact of substance use on the individual.  
 
The preceding evaluation categorized patients into the inclusion and exclusion criteria.  The inclusion criteria are 
AUD/OUD moderate dependency, history of moderate withdrawal, frequency of use is greater or equal to every 4-
hours, common psychiatric disorders with moderate severity, and the social determinants include males, females, 
other, African American, Caucasians, Hispanics, age range 18 to 70, and a support person.  The exclusion criteria 
are pregnant women undergoing alcohol or opioid withdrawal, unmanaged diabetes with A1C >12 mg/dl and or 
hypertension with BP >160/100, severe somatic disorders, history of epilepsy, history of delirium tremors, acute 
mania, severe psychosis, severe panic attacks, history of late Alzheimer with AUD/OUD, Unresolved traumatic 
brain history with AUD, history of conversion disorder and the excluding social factor is living alone and having no 
support person.  
 
When an individual is determined eligible for outpatient detoxification, and readiness is expressed.  Education and 
resources about the process of detoxification are provided to the patient.  
The patient with AUD is accompanied by a support person and arrives at the clinic one hour before they experience 
withdrawal symptoms.  The patient brings their own food to the clinic.  The CIWA protocol is used to assess and 
manage the patient using approved medications for detoxification.  Patients are usually discharged home between 4 
to 6-hours of detox after consistent CIWA scores below 8 for at least 2 hours.  The patient returns to the clinic the 
following morning to undergo the CIWA protocol process.  The patient with OUD arrives at the clinic in a state of 
mild to moderate withdrawal.  The COW protocol is used to assess and manage the patient using approved 
medications.  The patients are usually discharged home after consistent COW scores below 6 for two hours. 
Detoxification at the stabilization stage is determined successful when AUD/OUD patient’s CIWA score 
consistently stays below 8 for 2 days and COW scores consistently below 6 for 2 days.  The use of FDA-approved 
medications for this stage of detoxification is essential for a better outcome (ASAM, 2013; SAMHSA, 2019) 
 
Assessment of readiness to continue to the next phase of substance treatment is important to a patient’s recovery 
because detoxification in itself is not substance treatment.  Education is provided to patients and resources about 
maintenance drugs, individual therapy, and group therapy are given to patients.  Some patients elect to receive only 
maintenance drugs monthly or daily for AUD, biweekly to monthly for OUD patients.  Most patients receive 
maintenance drugs and continue with counseling and behavioral modifications learning from group therapy 
(SAMHSA, 2019). 
 
Alaska Treatment Center Biopsychosocial Model for Detoxification Stages 
 
 EVALUATION 
STABILIZATION READINESS FOR 
CONTINUITY OF 
CARE 
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Appendix D  
Cost-Benefit Analysis  
Cost Month 1 Month 2 Month 3   Total Cost 
Paper and 
ink 














$0 $0 $0    
Benefit  $0 $0 
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 Appendix E  
Project Time Frame for Completion     
Date Proposed Activity Time Frame/Due Date Expected Outcome 
July 6, 2020 
Project proposal 
presentation 
1 day To complete the proposal presented by 
the end of July 6, 2020. 
July 7, 2020 Prepare IRB application 1 week To complete the IRB forms and have all 
signees signed and ready for submission 
within 1 week. 
July 20, 2020 Submit full IRB application  1 to 4 weeks To submit IRB forms by July 20 and 
receive approval by the end of August 20. 
August 20, 2020 Distribute survey and collect data 1 to 2 weeks To complete the distribution of surveys 
by the end of August 25 and collect data 
by September 2, 2020. 
August 21, 2020 Notify IRB of any changes 1 week To notify IRB if the data collection may 
need some additions beyond the previous 
request by the end of August 25, 2020. 
September 2, 2020 Meeting with Chair and committee  1 week Submit data collected and data analysis to 
Chair and committee for review and plan 
to implement by the end of September 7, 
2020. 
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September 7, 2020 
Implementation 
Final data collection, analysis and write 
up 
3 weeks To implement the project at Alaska 
Treatment Center by the end of 
September 12, 2020.  To complete the 
final data collection, analysis, and write-
up by September 30, 2020. 
September 27, 2020 
Expert review of analysis and statistics 
1 week To complete expert review and edit by 
the end of September 30. 
November 2, 2020 
Meeting with Chair and committee 
  
1 day To receive approval for selected journals 
for publication by the end of November 
2, 2020. 
  
November 3, 2020 
Preparation for publication 
2 weeks To complete publication write-up and 
submit to at least one peer-reviewed 
journal by the end of November 20. 
February 20, 2021 
Preparation for PowerPoint presentation 
1 week To complete the write-up for PowerPoint 
presentation within 1 week. 
April 21, 2021 
DNP project defense 
2 weeks To pass the project defense and complete 
all recommended additions and 
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Appendix F 
Table 2a  
Oblique-Rotated Principal Component Analysis Loadings—Part A Survey Items 
Variable PC1 PC2 PC3 
Q10a: Did the clinicians talk to you in a way that 
was easy to understand 
0.213 0.198 0.564 
Q11a: Did you have confidence in the clinician's 
professional competence? 
0.880 -0.248 -0.051 
Q12a: To what degree did you perceive that the 
clinicians cared about you? 
0.749 -0.186 0.383 
Q13a: Did you get enough time to talk and interact 
with the clinicians? 
0.695 -0.322 0.422 
Q14a: Did the other staff talk to you in a way that 
was easy to understand? 
0.259 0.672 -0.273 
Q15a: Do you have confidence in the other staff's 
professional skills? 
0.536 0.735 -0.018 
Q16a: To what degree did you perceive that the 
other staff cared about you? 
0.724 0.465 0.149 
Q18a: Did you perceive the other staff to be 
interested in your description of your situation? 
0.858 0.271 0.132 
Q19a: Did you get enough time to talk and interact 
with the other staff? 
0.802 0.040 -0.062 
Q20a: Were you given the necessary information 
about how detoxification would be carried out? 
0.796 -0.226 -0.245 
Q21a: Did you get sufficient information about 
your diagnosis? 
0.634 -0.240 -0.265 
Q22a: Did you perceive the treatment you 
received as suited to your situation? 
0.816 -0.309 -0.160 
Q23a: Were you involved in any decision 
involving your treatment? 
0.748 -0.171 -0.070 
Q24a: Did you perceive the institution’s work as 
well organized? 
0.758 -0.037 -0.461 
Q25a: To what extent did Alaska Treatment 
Center prepare you for continuity of care after the 
detoxification? 
0.742 0.077 -0.006 
Q26a: To what extent did the organization work 
with other facilities to ensure your smooth 
0.678 0.016 -0.284 
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transition to the next phase of substance treatment 
after detoxification? 
Q27a: Did you have to wait after your initial 
evaluation to be scheduled for detoxification at 
Alaska Treatment Center? 
-0.076 -0.616 0.020 
Q28a: Overall, what benefit have you had from the 
care at the institution? 
0.542 -0.006 0.640 
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Appendix G 
Table 2b  
Oblique-Rotated Principal Component Analysis Loadings—Part B Survey Items 
Variable PC1 PC2 PC3 
Q10b: How important was this to you? 0.721 -0.276 0.406 
Q11b: How important was this to you? 0.818 -0.214 0.366 
Q12b: How important was this to you? 0.708 -0.228 0.457 
Q13b: How important was this to you? 0.845 -0.102 0.092 
Q14b: How important was this to you? 0.670 0.677 0.111 
Q15b: How important was this to you? 0.577 0.641 0.253 
Q16b: How important was this to you? 0.738 0.547 0.112 
Q18b: How important was this to you? 0.842 0.211 0.241 
Q19b: How important was this to you? 0.857 -0.072 -0.103 
Q20b: How important was this to you? 0.832 0.041 -0.310 
Q21b: How important was this to you? 0.837 0.007 -0.065 
Q22b: How important was this to you? 0.863 -0.184 -0.001 
Q23b: How important was this to you? 0.841 -0.245 0.110 
Q24b: How important was this to you? 0.819 0.032 -0.460 
Q25b: How important was this to you? 0.709 -0.084 -0.470 
Q26b: How important was this to you? 0.687 0.114 -0.610 
Q27b: How important was this to you? 0.613 -0.311 -0.032 
Q28b: How important was this to you? 0.691 -0.363 -0.058 
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